{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":145,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":145,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"89014c6b0aca","filters":{"venue":"Regular and Young Investigator Award Abstracts"}},"results":[{"id":"W4308399396","doi":"10.1136/jitc-2022-sitc2022.0558","title":"558 CTX130 allogeneic CRISPR-Cas9–engineered chimeric antigen receptor (CAR) T cells in patients with advanced clear cell renal cell carcinoma: Results from the phase 1 COBALT-RCC study","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Renal cell carcinoma; Fludarabine; Medicine; Clear cell renal cell carcinoma; Internal medicine; Refractory (planetary science); Chimeric antigen receptor; Oncology; Gastroenterology; Cyclophosphamide; Cancer research; Immunotherapy; Chemotherapy; Cancer; Biology","authors":[{"name":"Sumanta Pal","is_ca":false},{"name":"Ben Tran","is_ca":false},{"name":"John Haanen","is_ca":false},{"name":"Michael E. Hurwitz","is_ca":false},{"name":"Adrian G. Sacher","is_ca":true},{"name":"Neeraj Agarwal","is_ca":false},{"name":"Nizar Tannir","is_ca":false},{"name":"Elizabeth Budde","is_ca":false},{"name":"Simon J. Harrison","is_ca":false},{"name":"Sebastian Klobuch","is_ca":false},{"name":"Sagar S. Patel","is_ca":false},{"name":"Mary Lee Dequeant","is_ca":false},{"name":"Verena Karsten","is_ca":false},{"name":"Kaitlyn Cohen","is_ca":false},{"name":"Ellen B. Gurary","is_ca":false},{"name":"Henia Dar","is_ca":false},{"name":"Anna Ma","is_ca":false},{"name":"A. Sharma","is_ca":false},{"name":"Samer A. Srour","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01358275220468149,"gpt":0.2454665609501217,"spread":0.2318838087454402,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005973821,0.0003598443,0.0006994118,0.0001080091,0.0001861004,0.0005120121,0.0002340271,0.0003559987,0.001107798],"category_scores_gemma":[0.000258267,0.0001396843,0.000545935,0.0001727429,0.000269265,0.0002323151,0.0001437809,0.000823627,0.0003149],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006885562,"about_ca_system_score_gemma":0.0007207477,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001648552,"about_ca_topic_score_gemma":0.003364159,"domain_scores_codex":[0.9998372,0.00005185568,0.000009403519,0.00003742701,0.00003076666,0.00003332213],"domain_scores_gemma":[0.9997697,0.00004043188,0.00004317423,0.00002140476,0.0000276732,0.00009762598],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3340463,0.0246348,0.1174477,0.0009689358,0.002594772,0.0005869261,0.0006652244,0.008614424,0.181475,0.0004981194,0.01703826,0.3114296],"study_design_scores_gemma":[0.198688,0.4401667,0.2935479,0.0001019404,0.002904129,0.001208694,0.0002469651,0.008079917,0.03081806,0.0004499429,0.02369869,0.00008919492],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957711,0.001606206,0.0002389578,0.0002317081,0.0000321668,0.0002206254,0.0006107881,0.0000371854,0.001251294],"genre_scores_gemma":[0.9965973,0.0006320971,0.0002890032,0.0002746932,0.00003436556,0.0001047016,0.001408083,0.00001108565,0.0006486274],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001648552,"threshold_uncertainty_score":0.004995823,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3104819140","doi":"10.1136/jitc-2020-sitc2020.0428","title":"428 Interim analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (mBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIs)","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Tolerability; Vismodegib; Internal medicine; Clinical endpoint; Interim analysis; Basal cell carcinoma; Progression-free survival; Oncology; Surgery; Gastroenterology; Randomized controlled trial; Chemotherapy; Adverse effect; Basal cell","authors":[{"name":"Karl D. Lewis","is_ca":false},{"name":"Ketty Peris","is_ca":false},{"name":"Aleksandar Sekulić","is_ca":false},{"name":"Alexander Stratigos","is_ca":false},{"name":"Lara Dunn","is_ca":false},{"name":"Zeynep Eroglu","is_ca":false},{"name":"Anne Lynn S. Chang","is_ca":false},{"name":"Michael R. Migden","is_ca":false},{"name":"Siyu Li","is_ca":false},{"name":"Kosalai Kal Mohan","is_ca":false},{"name":"Ebony Coates","is_ca":false},{"name":"Emmanuel Chiebuka Okoye","is_ca":false},{"name":"Jean‐François Baurain","is_ca":false},{"name":"Oliver Bechter","is_ca":false},{"name":"Axel Hauschild","is_ca":false},{"name":"Marcus O. Butler","is_ca":true},{"name":"Leonel F. Hernandez‐Aya","is_ca":false},{"name":"Lisa Licitra","is_ca":false},{"name":"Rogerio I. Neves","is_ca":false},{"name":"E.P. Yanez Ruiz","is_ca":false},{"name":"Frank Seebach","is_ca":false},{"name":"David M. Weinreich","is_ca":false},{"name":"George D. Yancopoulos","is_ca":false},{"name":"Israel Lowy","is_ca":false},{"name":"Timothy G. Bowler","is_ca":false},{"name":"Matthew G. Fury","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02856484540316573,"gpt":0.270789013981223,"spread":0.2422241685780573,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00771669,0.001181005,0.001702522,0.0003605863,0.0004263147,0.001247496,0.0005448989,0.0008523693,0.007759927],"category_scores_gemma":[0.004335498,0.000485398,0.003733375,0.0003321024,0.0003929534,0.0005932746,0.0004315696,0.002198295,0.001129687],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007286838,"about_ca_system_score_gemma":0.002147507,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003422427,"about_ca_topic_score_gemma":0.001139515,"domain_scores_codex":[0.9969215,0.00188594,0.0001483715,0.000329856,0.0003211724,0.0003931347],"domain_scores_gemma":[0.9975247,0.0008588855,0.0007073269,0.000372319,0.000186808,0.0003500206],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8557347,0.008406758,0.02163962,0.000831515,0.004830241,0.0002833608,0.0001305457,0.007008335,0.01600726,0.0008216046,0.02400035,0.06030567],"study_design_scores_gemma":[0.3930874,0.4099294,0.1066519,0.0002013784,0.008972457,0.0008359815,0.000159887,0.01460616,0.02416239,0.003344568,0.0378986,0.000150012],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9405537,0.003117868,0.006518967,0.001439719,0.0006062997,0.009351023,0.02358409,0.0004857221,0.01434271],"genre_scores_gemma":[0.9486127,0.0006591468,0.008932723,0.002229493,0.0002400268,0.01342981,0.01922468,0.0002096344,0.006461651],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007759927,"threshold_uncertainty_score":0.04081023,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3100538981","doi":"10.1136/jitc-2020-sitc2020.0379","title":"379 Initial safety, efficacy, and product attributes from the SURPASS trial with ADP-A2M4CD8, a SPEAR T-cell therapy incorporating an affinity optimized TCR targeting MAGE-A4 and a CD8α co-receptor","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"CD8; Medicine; T-cell receptor; Internal medicine; Antigen; Cancer; T cell; Gastroenterology; Oncology; Immunology; Immune system","authors":[{"name":"David S. Hong","is_ca":false},{"name":"Jeffrey Clarke","is_ca":false},{"name":"Tanner M. Johanns","is_ca":false},{"name":"Partow Kebriaei","is_ca":false},{"name":"John V. Heymach","is_ca":false},{"name":"Ahmed Galal","is_ca":false},{"name":"Samuel D. Saibil","is_ca":true},{"name":"Adrian G. Sacher","is_ca":true},{"name":"Francine Brophy","is_ca":false},{"name":"Gareth Betts","is_ca":false},{"name":"Natalie Bath","is_ca":false},{"name":"William Spinner","is_ca":false},{"name":"Alex J. Tipping","is_ca":false},{"name":"Jessica Tucci","is_ca":false},{"name":"Raymond Luke","is_ca":false},{"name":"Trupti Trivedi","is_ca":false},{"name":"Quan Lin","is_ca":false},{"name":"Jean‐Marc Navenot","is_ca":false},{"name":"Paula M. Fracasso","is_ca":false},{"name":"Karen Miller","is_ca":false},{"name":"Elliot Norry","is_ca":false},{"name":"Mark E. Dudley","is_ca":false},{"name":"Marcus O. Butler","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05083607555745884,"gpt":0.2917466332077279,"spread":0.240910557650269,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008312513,0.0004039794,0.000607916,0.000178731,0.0002849887,0.0008003062,0.0002456715,0.0005471027,0.009161918],"category_scores_gemma":[0.0006825455,0.0001311445,0.0007176354,0.0002444998,0.0002623519,0.0003737135,0.0002129056,0.00117866,0.001378825],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007850422,"about_ca_system_score_gemma":0.0008189744,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008434701,"about_ca_topic_score_gemma":0.002052281,"domain_scores_codex":[0.9996426,0.0001158292,0.00003203085,0.00004754466,0.00009497879,0.00006699381],"domain_scores_gemma":[0.999631,0.00008760576,0.00005712142,0.00002791199,0.00003724193,0.0001590084],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4685028,0.01875611,0.0239404,0.001103905,0.001187254,0.001002517,0.0002449608,0.006661091,0.1230549,0.001295026,0.02887215,0.3253789],"study_design_scores_gemma":[0.09476595,0.6296777,0.09426986,0.000189366,0.001779164,0.002306387,0.0001643523,0.003501612,0.06646082,0.001591491,0.1051796,0.0001137781],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.965351,0.002518254,0.001050534,0.0006358518,0.0001173315,0.001767789,0.01071345,0.00009511669,0.01775069],"genre_scores_gemma":[0.9671536,0.001438629,0.001287419,0.0009462998,0.0001001809,0.001023818,0.01806052,0.00006218573,0.009927367],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009161918,"threshold_uncertainty_score":0.03064966,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388042564","doi":"10.1136/jitc-2023-sitc2023.0695","title":"695 Efficacy and safety of trastuzumab deruxtecan (T-DXd) with durvalumab in patients with non-small cell lung cancer (HER2 altered NSCLC) who progressed on anti-PD1/PD-L1 therapy (HUDSON)","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Durvalumab; Medicine; Internal medicine; Clinical endpoint; Oncology; Tremelimumab; Lung cancer; Trastuzumab; non-small cell lung cancer (NSCLC); Adverse effect; Cancer; Immunotherapy; Clinical trial; Nivolumab; Ipilimumab; Breast cancer","authors":[{"name":"Parneet Cheema","is_ca":true},{"name":"Sylvia Hartl","is_ca":false},{"name":"Marianna Koczywas","is_ca":false},{"name":"Maximilian J. Hochmair","is_ca":false},{"name":"Frances A. Shepherd","is_ca":true},{"name":"Quincy S. Chu","is_ca":true},{"name":"Giuseppe Galletti","is_ca":false},{"name":"Mark Gustavson","is_ca":false},{"name":"Sonia Iyer","is_ca":false},{"name":"J. Carl Barrett","is_ca":false},{"name":"Brent Evans","is_ca":false},{"name":"Rakesh Kumar","is_ca":false},{"name":"Jan Cosaert","is_ca":false},{"name":"Keunchil Park","is_ca":false},{"name":"John V. Heymach","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01045595203227388,"gpt":0.2406354814381965,"spread":0.2301795294059226,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006289584,0.0003385029,0.0008025435,0.000181364,0.0001818544,0.0005712874,0.0002913223,0.0003731569,0.001456483],"category_scores_gemma":[0.0006036645,0.0001928223,0.0006917281,0.000249081,0.0002779,0.0004140956,0.0002436195,0.00116689,0.0003170381],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009933496,"about_ca_system_score_gemma":0.0006810838,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002232753,"about_ca_topic_score_gemma":0.004917251,"domain_scores_codex":[0.999803,0.00008407285,0.00001434767,0.00002904599,0.00002277697,0.00004688386],"domain_scores_gemma":[0.9996915,0.00006052273,0.00006253272,0.00001894286,0.00001761513,0.0001488404],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6043335,0.02208881,0.0431793,0.0003805397,0.001332339,0.0004726202,0.0003231668,0.004473315,0.062434,0.0002125102,0.003282758,0.2574872],"study_design_scores_gemma":[0.1149551,0.7042704,0.1571097,0.00006457468,0.0009228013,0.0007653218,0.0001512525,0.004048732,0.01193003,0.0002128443,0.005524097,0.00004512555],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979214,0.0008124931,0.0000642465,0.00008652586,0.00002404527,0.00007127639,0.0002652334,0.0000122092,0.0007425506],"genre_scores_gemma":[0.9977655,0.0004595877,0.0001975803,0.0001519386,0.0000327185,0.00005509111,0.0007180253,0.000006697578,0.0006128133],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002232753,"threshold_uncertainty_score":0.007207334,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388084134","doi":"10.1136/jitc-2023-sitc2023.0741","title":"741 TWT-101: a first-in-clinic study of CFI-402411, a hematopoietic progenitor Kinase-1 (HPK1) inhibitor, as single agent or combined with pembrolizumab in subjects with advanced solid malignancies","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta; University Health Network; Ottawa Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Adverse effect; Gastroenterology; Oncology; Toxicity; Cancer; Immunotherapy","authors":[{"name":"Kyriakos P. Papadopoulos","is_ca":false},{"name":"Scott A. Laurie","is_ca":true},{"name":"Alexander I. Spira","is_ca":false},{"name":"Siqing Fu","is_ca":false},{"name":"Erika Hamilton","is_ca":false},{"name":"Brigette Ma","is_ca":false},{"name":"Judy S. Wang","is_ca":false},{"name":"Manish Sharma","is_ca":false},{"name":"Quincy S. Chu","is_ca":true},{"name":"Anna Spreafico","is_ca":true},{"name":"Mark R. Bray","is_ca":false},{"name":"Dih-Yih Chen","is_ca":false},{"name":"Emily Roberts-Thomson","is_ca":false},{"name":"Roger Sidhu","is_ca":false},{"name":"Omid Hamid","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02282469974766373,"gpt":0.2716791618740001,"spread":0.2488544621263364,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001212453,0.001786602,0.001943802,0.0005340847,0.0006144603,0.00114285,0.0009526636,0.001694109,0.006691419],"category_scores_gemma":[0.0006321375,0.0007980342,0.001222413,0.0003588515,0.001127582,0.001002599,0.0003097609,0.004454064,0.001854779],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001312703,"about_ca_system_score_gemma":0.001897605,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001814635,"about_ca_topic_score_gemma":0.005028195,"domain_scores_codex":[0.9995351,0.0002039621,0.00001721062,0.00007370164,0.00004101899,0.0001291449],"domain_scores_gemma":[0.9992763,0.00009141705,0.00007475488,0.00003883902,0.00003961865,0.000478886],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5388648,0.258872,0.006685676,0.0006889848,0.00122985,0.0005415369,0.0002893087,0.002068231,0.07183265,0.0003022203,0.009352356,0.1092724],"study_design_scores_gemma":[0.2287882,0.7517119,0.009956421,0.0000200697,0.000333993,0.0002292691,0.00005840702,0.0008988043,0.005506395,0.00008874874,0.002375956,0.00003198015],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914068,0.001180719,0.0003832022,0.00046028,0.0001537899,0.002110761,0.001063295,0.0001318807,0.003109373],"genre_scores_gemma":[0.9847594,0.001277424,0.001395462,0.001146518,0.0002894178,0.002225752,0.002072325,0.00004802345,0.006785743],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006691419,"threshold_uncertainty_score":0.02238506,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3212914573","doi":"10.1136/jitc-2021-sitc2021.509","title":"509 A first-in-human phase 1 study of NL-201 in patients with relapsed or refractory cancer","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; CD8; Immunotherapy; Refractory (planetary science); Cytotoxic T cell; Cancer; Internal medicine; Oncology; Cancer immunotherapy; Dosing; Immune system; Cancer research; Immunology; Chemistry; Biology; In vitro","authors":[{"name":"Aung Naing","is_ca":false},{"name":"Margaret K. Callahan","is_ca":false},{"name":"Brian A. Costello","is_ca":false},{"name":"Brendan D. Curti","is_ca":false},{"name":"Evan Hall","is_ca":false},{"name":"Aaron R. Hansen","is_ca":true},{"name":"Georgina V. Long","is_ca":false},{"name":"Anthony M. Joshua","is_ca":false},{"name":"Brooke Shankles","is_ca":false},{"name":"Umut Y. Ulge","is_ca":false},{"name":"Andrew Weickhardt","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01861948697596352,"gpt":0.2867674058962363,"spread":0.2681479189202728,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001360078,0.001494447,0.001475503,0.0004258247,0.0005143996,0.0007480722,0.001019901,0.001286494,0.005209862],"category_scores_gemma":[0.0005407744,0.0005578325,0.001103328,0.0003031485,0.0008515335,0.0006337019,0.0003415805,0.002574722,0.001391498],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001103726,"about_ca_system_score_gemma":0.002497431,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001859535,"about_ca_topic_score_gemma":0.004513534,"domain_scores_codex":[0.9996127,0.0001756003,0.00001621321,0.00005483582,0.00004290912,0.00009772205],"domain_scores_gemma":[0.9994629,0.00007761666,0.00006229119,0.00005794296,0.00004162063,0.0002976832],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4042835,0.2502673,0.01040845,0.00111072,0.001131182,0.0008659376,0.0004515257,0.004850471,0.1417144,0.0005105326,0.01788375,0.1665223],"study_design_scores_gemma":[0.2608171,0.7098122,0.009291735,0.00003381917,0.0002832365,0.0004595189,0.00007306667,0.001809078,0.01044831,0.0002082131,0.006720019,0.00004364784],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9845084,0.001510837,0.001057721,0.000678968,0.0001934359,0.005976517,0.002431132,0.0002447156,0.003398371],"genre_scores_gemma":[0.9756187,0.00166325,0.003608409,0.002194109,0.0002057352,0.005480896,0.005299154,0.00008952386,0.005840247],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005209862,"threshold_uncertainty_score":0.01742876,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3214459545","doi":"10.1136/jitc-2021-sitc2021.538","title":"538 Updated survival of patients with previously treated metastatic uveal melanoma who received tebentafusp","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Melanoma; Refractory (planetary science); Internal medicine; Gastroenterology; Nuclear medicine; Urology; Surgery; Oncology; Cancer research; Biology","authors":[{"name":"Joseph J. Sacco","is_ca":false},{"name":"Richard D. Carvajal","is_ca":false},{"name":"Marcus O. Butler","is_ca":true},{"name":"Alexander N. Shoushtari","is_ca":false},{"name":"Jessica C. Hassel","is_ca":false},{"name":"Alexandra P. Ikeguchi","is_ca":false},{"name":"Leonel F. Hernandez‐Aya","is_ca":false},{"name":"Paul Nathan","is_ca":false},{"name":"Omid Hamid","is_ca":false},{"name":"Josep M. Piulats","is_ca":false},{"name":"Matthew J. Rioth","is_ca":false},{"name":"Jason J. Luke","is_ca":false},{"name":"Enrique Espinosa","is_ca":false},{"name":"Serge Leyvraz","is_ca":false},{"name":"Chris Holland","is_ca":false},{"name":"Michelle L. McCully","is_ca":false},{"name":"Shaad E. Abdullah","is_ca":false},{"name":"Takami Sato","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01325478381405026,"gpt":0.2431491939966965,"spread":0.2298944101826462,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003473966,0.000160653,0.0003671227,0.0003440129,0.0001715028,0.0003894902,0.000185045,0.0003121646,0.003147798],"category_scores_gemma":[0.0005374362,0.00008263755,0.0004452239,0.0003514014,0.00008325585,0.000300046,0.0001679587,0.0004316256,0.0004777281],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004679773,"about_ca_system_score_gemma":0.000272903,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002145421,"about_ca_topic_score_gemma":0.004203709,"domain_scores_codex":[0.999855,0.00002463713,0.00001492973,0.00003370633,0.00003824319,0.00003337715],"domain_scores_gemma":[0.999494,0.00008453714,0.0002244415,0.00003441998,0.00007512911,0.00008737849],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02612071,0.0003889562,0.8561895,0.0002477279,0.0006788895,0.0004770527,0.000116893,0.002137631,0.008551008,0.0001362115,0.0071288,0.09782676],"study_design_scores_gemma":[0.0005275385,0.004617874,0.9836717,0.00003086452,0.0004377979,0.0007989291,0.00003385114,0.001041174,0.001854835,0.00008317589,0.006881944,0.00002031094],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9777234,0.001832781,0.0002748761,0.0002197655,0.0000303737,0.00006956011,0.01350973,0.00007162739,0.006267808],"genre_scores_gemma":[0.9845445,0.0003696943,0.0001954608,0.0001948024,0.0000333198,0.00005759799,0.0130599,0.00001004621,0.001534639],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003147798,"threshold_uncertainty_score":0.01053047,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388047619","doi":"10.1136/jitc-2023-sitc2023.0778","title":"778 TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy combined with pembrolizumab (pembro) vs pembro alone in treatment-naïve unresectable or metastatic melanoma","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Melanoma; Cancer; Internal medicine; Oncology; Surgery; Immunotherapy; Cancer research","authors":[{"name":"Daniel J. Olson","is_ca":false},{"name":"James Larkin","is_ca":false},{"name":"Young Ki Hong","is_ca":false},{"name":"Sajeve Thomas","is_ca":false},{"name":"Juan Martín-Liberal","is_ca":false},{"name":"Andrew J.S. Furness","is_ca":false},{"name":"Patrick Terheyden","is_ca":false},{"name":"Gino K. In","is_ca":false},{"name":"Andrew Poklepovic","is_ca":false},{"name":"Yazan Samhouri","is_ca":false},{"name":"Philip E. Lammers","is_ca":false},{"name":"Victoria Atkinson","is_ca":false},{"name":"Idit Peretz","is_ca":false},{"name":"Marcus O. Butler","is_ca":true},{"name":"Friedrich Graf Finckenstein","is_ca":false},{"name":"Jeffrey Chou","is_ca":false},{"name":"Xiao Wu","is_ca":false},{"name":"Giri Sulur","is_ca":false},{"name":"Wen Shi","is_ca":false},{"name":"John B.A.G. Haanen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04680987990646559,"gpt":0.3167563591817601,"spread":0.2699464792752946,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001734693,0.001533043,0.001816995,0.0004435331,0.0005872796,0.001072324,0.001067581,0.00200255,0.005738661],"category_scores_gemma":[0.0008730602,0.000657143,0.001608192,0.0002770514,0.001058696,0.0009372074,0.0003296702,0.004107145,0.001332111],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001102903,"about_ca_system_score_gemma":0.002511478,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001531378,"about_ca_topic_score_gemma":0.005009654,"domain_scores_codex":[0.9995036,0.0002526163,0.00002196924,0.00006989593,0.00005552431,0.00009641601],"domain_scores_gemma":[0.999036,0.0001663364,0.000169569,0.00005950707,0.00005371962,0.0005148712],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8323248,0.08862117,0.001774971,0.0005321907,0.0006606335,0.0001457992,0.000121339,0.001207853,0.03778022,0.0002700039,0.004697056,0.03186406],"study_design_scores_gemma":[0.605453,0.3863767,0.003297207,0.00002243924,0.0002446652,0.00008001075,0.00002873207,0.0007133961,0.002271001,0.0001581345,0.001328452,0.00002623313],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848316,0.001390061,0.0005072867,0.000800342,0.0004123605,0.00640967,0.001889386,0.0001545793,0.003604962],"genre_scores_gemma":[0.975836,0.001546504,0.002499647,0.002192277,0.0004957932,0.007292068,0.003317981,0.00007336109,0.006746521],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005738661,"threshold_uncertainty_score":0.01919776,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388048272","doi":"10.1136/jitc-2023-sitc2023.0766","title":"766 A clinical trial to evaluate the safety, tolerability and preliminary efficacy of VG161 in combination with Nivolumab in patients with advanced pancreatic cancer","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver Biotech (Canada)","funders":"","keywords":"Tolerability; Medicine; Pharmacodynamics; Nivolumab; Oncolytic virus; Internal medicine; Pharmacokinetics; Gastroenterology; Refractory (planetary science); Pancreatic cancer; Adverse effect; Cancer; Oncology; Urology; Pharmacology; Immunotherapy; Biology","authors":[{"name":"Yinan Shen","is_ca":false},{"name":"Aijun Qin","is_ca":false},{"name":"Yiting Qiu","is_ca":false},{"name":"Xinyan Jin","is_ca":false},{"name":"Wei Song","is_ca":false},{"name":"Fang Tian","is_ca":false},{"name":"Xingmei Liang","is_ca":false},{"name":"Yuwei Li","is_ca":false},{"name":"David S.P. Tan","is_ca":false},{"name":"Ronghua Zhao","is_ca":true},{"name":"Xueli Bai","is_ca":false},{"name":"Tingbo Liang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02569682065945692,"gpt":0.331014626253827,"spread":0.3053178055943701,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007720109,0.0006116524,0.001106107,0.0001866885,0.00026279,0.0006848984,0.0004103614,0.0007652088,0.003770207],"category_scores_gemma":[0.0003924847,0.0002381097,0.0007672167,0.0002334978,0.0005947063,0.0004749921,0.0001937367,0.00162855,0.000772005],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006301521,"about_ca_system_score_gemma":0.001107845,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006963836,"about_ca_topic_score_gemma":0.001850275,"domain_scores_codex":[0.9997547,0.0001146876,0.00001377908,0.00003945169,0.00002529497,0.00005205876],"domain_scores_gemma":[0.9997122,0.00005130004,0.00005280224,0.00002403898,0.00001501091,0.0001446768],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7765579,0.03578946,0.006435923,0.0006490243,0.0007447383,0.0002886841,0.0001518264,0.002689295,0.06281988,0.0002367867,0.002539608,0.1110969],"study_design_scores_gemma":[0.3387785,0.638162,0.009858607,0.00003538429,0.0002470571,0.0003086501,0.00005365473,0.001373515,0.007534832,0.0002163872,0.003404039,0.00002750486],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994902,0.001442764,0.0002062292,0.0002329163,0.00008584281,0.0009843369,0.0004494279,0.00004663242,0.001649912],"genre_scores_gemma":[0.9945852,0.0007132972,0.0007634585,0.0003751784,0.00007885121,0.0007561625,0.0007768262,0.00001516745,0.001935875],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003770207,"threshold_uncertainty_score":0.01261258,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3103926827","doi":"10.1136/jitc-2020-sitc2020.0155","title":"155 iPSC-derived NK cells mediate robust anti-tumor activity against glioblastoma","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Cytotoxic T cell; Cancer research; Immunotherapy; Adoptive cell transfer; NK-92; Cytotoxicity; Perforin; Biology; Immunology; Interleukin 21; Immune system; CD8; T cell; In vitro","authors":[{"name":"Jeffrey S. Miller","is_ca":false},{"name":"Frank Cichocki","is_ca":false},{"name":"Jianfang Ning","is_ca":false},{"name":"Ryan Bjordahl","is_ca":false},{"name":"Zachary Davis","is_ca":false},{"name":"Katie Tuininga","is_ca":false},{"name":"Hongbo Wang","is_ca":false},{"name":"Paul Rogers","is_ca":false},{"name":"Moyar Ge","is_ca":false},{"name":"Tom Lee","is_ca":false},{"name":"Bob Valamehr","is_ca":false},{"name":"Clark Chen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03077527250515736,"gpt":0.2557324741213075,"spread":0.2249572016161501,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001408707,0.0003836277,0.0003214347,0.0002344839,0.00009909988,0.0003509896,0.0002416886,0.0003430211,0.002957201],"category_scores_gemma":[0.0001341754,0.0001238677,0.000315531,0.0001808935,0.000168647,0.0001774595,0.0002261243,0.0008301246,0.001308317],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002235996,"about_ca_system_score_gemma":0.0002387617,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000320225,"about_ca_topic_score_gemma":0.0003637726,"domain_scores_codex":[0.9998137,0.00002097603,0.00004092487,0.00002863135,0.00005451903,0.00004127827],"domain_scores_gemma":[0.9999322,0.00001346387,0.00001587363,0.00001107239,0.00001249848,0.00001497763],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002797088,0.0001344866,0.0002018923,0.0001039216,0.00001061329,0.00006497085,0.00002675956,0.0002524925,0.9936168,0.0001725329,0.0004679258,0.004667891],"study_design_scores_gemma":[0.00005377324,0.0004408228,0.002106078,0.00001433448,0.00002677599,0.0001499533,0.00002853482,0.0006693749,0.9913258,0.00007615848,0.005102163,0.000006162655],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9844677,0.001951764,0.003820289,0.0002003631,0.0001574003,0.0001346957,0.002111001,0.0002476096,0.006909154],"genre_scores_gemma":[0.9887078,0.001075716,0.002888377,0.0002525201,0.00003537139,0.0001396529,0.003115964,0.00005773265,0.003726893],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002957201,"threshold_uncertainty_score":0.009892821,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3103606205","doi":"10.1136/jitc-2020-sitc2020.0307","title":"307 Atezolizumab plus vemurafenib and cobimetinib provides favorable survival outcomes in patients with high tumor mutation burden and proinflammatory gene signature in the phase 3 IMspire150 study","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"Pritzker School of Medicine; American Society of Hematology","keywords":"Vemurafenib; Internal medicine; Medicine; Atezolizumab; Hazard ratio; Oncology; Progression-free survival; Melanoma; Pembrolizumab; Immunotherapy; Cancer research; Cancer; Overall survival; Metastatic melanoma; Confidence interval","authors":[{"name":"Karl D. Lewis","is_ca":false},{"name":"Paolo A. Ascierto","is_ca":false},{"name":"Caroline Robert","is_ca":false},{"name":"Rodrigo Ramella Munhoz","is_ca":false},{"name":"Gabriella Liszkay","is_ca":false},{"name":"Luis De La Cruz Marino","is_ca":false},{"name":"Judit Oláh","is_ca":false},{"name":"Paola Queirolo","is_ca":false},{"name":"Jacek Mackiewicz","is_ca":false},{"name":"Kalpit Shah","is_ca":false},{"name":"Harper Forbes","is_ca":true},{"name":"Christian Hertig","is_ca":true},{"name":"Yibing Yan","is_ca":false},{"name":"Ralf Gutzmer","is_ca":false},{"name":"Grant A. McArthur","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.00991258563327047,"gpt":0.2194322897048243,"spread":0.2095197040715538,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001374704,0.0005611978,0.001259735,0.0001547834,0.0002621761,0.0007117881,0.0003610272,0.0005106766,0.002176299],"category_scores_gemma":[0.0006001029,0.0002846688,0.001520901,0.0002126638,0.00030919,0.0003413529,0.0002524566,0.001092993,0.0004689617],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004396966,"about_ca_system_score_gemma":0.000724222,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005968795,"about_ca_topic_score_gemma":0.001994019,"domain_scores_codex":[0.9996508,0.0001721763,0.00002278203,0.00005716903,0.00003084629,0.00006613893],"domain_scores_gemma":[0.9995758,0.00007084593,0.0001010329,0.00005251143,0.00002916022,0.0001705779],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8315962,0.01029985,0.06184182,0.0004421223,0.00303867,0.0002495746,0.00009447566,0.001548764,0.02726946,0.0002242318,0.007797039,0.05559776],"study_design_scores_gemma":[0.4599849,0.1976891,0.3176811,0.0001361483,0.005201667,0.0007746153,0.0001516472,0.005009988,0.006068602,0.0008308642,0.006334043,0.0001373065],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968809,0.0009569397,0.0001308451,0.0002201332,0.00006855277,0.0001908152,0.0007319091,0.00001858638,0.0008013661],"genre_scores_gemma":[0.9966027,0.0003614527,0.0002843326,0.0004452523,0.0001201342,0.0002189029,0.001475787,0.000007107031,0.000484353],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002176299,"threshold_uncertainty_score":0.007280409,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308385775","doi":"10.1136/jitc-2022-sitc2022.0750","title":"750 TWT-101: a first-in-clinic, phase 1/2 study of CFI-402411, a hematopoietic progenitor kinase-1 (HPK1) inhibitor, as a single agent and in combination with pembrolizumab in subjects with advanced solid malignancies","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Gastroenterology; Oncology; Cancer; Immunotherapy","authors":[{"name":"Kyriakos Papadopoulos","is_ca":false},{"name":"Siqing Fu","is_ca":false},{"name":"Erika Hamilton","is_ca":false},{"name":"Alexander I. Spira","is_ca":false},{"name":"Scott A. Laurie","is_ca":true},{"name":"Judy Wang","is_ca":false},{"name":"Brigette Ma","is_ca":false},{"name":"Anna Spreafico","is_ca":true},{"name":"Manish Sharma","is_ca":false},{"name":"Quincy S. Chu","is_ca":false},{"name":"Mark Bray","is_ca":false},{"name":"Glenn Michelson","is_ca":false},{"name":"Dih-Yih Chen","is_ca":false},{"name":"Linh Nguyen","is_ca":false},{"name":"Emily Roberts-Thomson","is_ca":false},{"name":"Omid Hamid","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01073260727766131,"gpt":0.2477301152551453,"spread":0.236997507977484,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001397347,0.002093846,0.001687224,0.000717882,0.0007460933,0.001570763,0.001431613,0.002449277,0.006620057],"category_scores_gemma":[0.0005219143,0.0009182255,0.001234369,0.0004562361,0.001068297,0.001091339,0.0003423432,0.005715627,0.002473455],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001959166,"about_ca_system_score_gemma":0.00283185,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002603728,"about_ca_topic_score_gemma":0.009569752,"domain_scores_codex":[0.9994463,0.0001947575,0.00002020476,0.00009764932,0.000076942,0.0001640193],"domain_scores_gemma":[0.9994426,0.00004891954,0.00005677911,0.0000336833,0.0000419832,0.0003759678],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2227568,0.2932779,0.005025026,0.001294045,0.001557229,0.0006701524,0.000474895,0.005894072,0.260356,0.001169045,0.03173095,0.1757938],"study_design_scores_gemma":[0.2854302,0.6734461,0.009808149,0.00005825221,0.0004521546,0.0005156843,0.00009896795,0.001800607,0.01759556,0.0004166003,0.01030061,0.00007710043],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9637858,0.003573238,0.00185822,0.001843605,0.0004760493,0.01061314,0.006322716,0.0005868185,0.01094046],"genre_scores_gemma":[0.9477923,0.003592833,0.006439183,0.004676518,0.000348705,0.01032555,0.01011127,0.0001717081,0.01654195],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006620057,"threshold_uncertainty_score":0.02214628,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3103244011","doi":"10.1136/jitc-2020-sitc2020.0351","title":"351 Pembrolizumab plus lenvatinib vs chemotherapy and lenvatinib monotherapy for recurrent/metastatic head and neck squamous cell carcinoma that progressed on platinum therapy and immunotherapy: LEAP-009","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"","keywords":"Lenvatinib; Pembrolizumab; Medicine; Oncology; Immunotherapy; Head and neck squamous-cell carcinoma; Chemotherapy; Internal medicine; Head and neck cancer; Head and neck; Radiation therapy; Surgery; Cancer","authors":[{"name":"Kevin J. Harrington","is_ca":false},{"name":"Ezra E.W. Cohen","is_ca":false},{"name":"L.L. Siu","is_ca":true},{"name":"Danny Rischin","is_ca":false},{"name":"Lisa Licitra","is_ca":false},{"name":"Jan B. Vermorken","is_ca":false},{"name":"Quynh‐Thu Le","is_ca":false},{"name":"Makoto Tahara","is_ca":false},{"name":"Jean‐Pascal Machiels","is_ca":false},{"name":"Natalyn Hawk","is_ca":false},{"name":"Joy Yang Ge","is_ca":false},{"name":"Behzad Bidadi","is_ca":false},{"name":"Ramona F. Swaby","is_ca":false},{"name":"Barbara Burtness","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04785480680630224,"gpt":0.2749732537829019,"spread":0.2271184469765996,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009399237,0.0005748938,0.001660243,0.000399167,0.0002871088,0.0010188,0.0005770821,0.0008999685,0.007958237],"category_scores_gemma":[0.0006994385,0.0003175245,0.001630596,0.0002989906,0.0005114945,0.0009701784,0.0003864839,0.00222267,0.000891497],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001098858,"about_ca_system_score_gemma":0.001598472,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001719481,"about_ca_topic_score_gemma":0.005524675,"domain_scores_codex":[0.999634,0.000158236,0.00002808507,0.00005092063,0.00003724886,0.00009140408],"domain_scores_gemma":[0.9994426,0.0001206089,0.00007959318,0.00002672381,0.00002606856,0.0003043426],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.923333,0.01280102,0.00172577,0.0005049245,0.001082664,0.00008805598,0.00005101638,0.0008026363,0.0075745,0.0001807031,0.00250179,0.04935399],"study_design_scores_gemma":[0.494346,0.4745173,0.01806674,0.0001262195,0.001946446,0.0002071545,0.00009650065,0.00224566,0.002708198,0.0003655689,0.005330724,0.00004358944],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9870608,0.004581751,0.0002235088,0.0008409918,0.0004644657,0.001377032,0.001221085,0.00007645131,0.004154026],"genre_scores_gemma":[0.9919868,0.001739649,0.0006769598,0.001086093,0.0002702894,0.0007555105,0.001254704,0.00001673064,0.002213278],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007958237,"threshold_uncertainty_score":0.02662295,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308383460","doi":"10.1136/jitc-2022-sitc2022.1185","title":"1185 Optimization of purine-based TLR7 agonists as payloads for immune-stimulating antibody conjugates (ISACs)","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Nuvation (Canada); Zymeworks (Canada)","funders":"","keywords":"Immune system; TLR7; Purine; Pharmacology; Antibody; Peripheral blood mononuclear cell; Splenocyte; In vitro; Chemistry; Cytokine; Cancer research; Immunology; Biology; Biochemistry; Toll-like receptor; Innate immune system","authors":[{"name":"Graham A. E. Garnett","is_ca":true},{"name":"Katina Mak","is_ca":true},{"name":"Renee Duan","is_ca":true},{"name":"Truman Hirkala-Schaefer","is_ca":true},{"name":"Manuel Lasalle","is_ca":true},{"name":"Nichole Escalante","is_ca":true},{"name":"Joy Guedia","is_ca":true},{"name":"Kara White Moyes","is_ca":true},{"name":"Sam Lawn","is_ca":true},{"name":"Raffaele Colombo","is_ca":true},{"name":"Jamie Rich","is_ca":true},{"name":"Stuart D. Barnscher","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02088711229255909,"gpt":0.3131224107280727,"spread":0.2922352984355136,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000163046,0.0002726943,0.0001588889,0.0001443841,0.00008462516,0.0001673199,0.0001609419,0.0002374758,0.001107869],"category_scores_gemma":[0.0001195521,0.00009384992,0.000151148,0.0001456709,0.00008484987,0.0001397624,0.000121173,0.0002278244,0.0004133597],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001643925,"about_ca_system_score_gemma":0.000129539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001725584,"about_ca_topic_score_gemma":0.0003955978,"domain_scores_codex":[0.9999087,0.00002387326,0.000008202286,0.00001536105,0.00002238839,0.0000213797],"domain_scores_gemma":[0.9999379,0.000009737881,0.00002213679,0.000004356387,0.000012133,0.00001362977],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000235436,0.0001023784,0.0001650682,0.00008688249,0.000008717302,0.00007502214,0.00001648376,0.0008898423,0.9922645,0.0001506151,0.0001210855,0.005884098],"study_design_scores_gemma":[0.00002442212,0.001008066,0.0004118287,0.000005785052,0.000008399062,0.00008370518,0.000009019673,0.001092866,0.9948585,0.00001651815,0.002475711,0.000005172064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907691,0.00128549,0.004712757,0.00005199327,0.00002195639,0.0001214423,0.0003066908,0.00006342977,0.002667251],"genre_scores_gemma":[0.9914827,0.0008204721,0.006109299,0.00004542777,0.000007469353,0.00007646852,0.0002869973,0.00001565719,0.001155464],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001107869,"threshold_uncertainty_score":0.003706217,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3212274217","doi":"10.1136/jitc-2021-sitc2021.374","title":"374 A phase IB trial of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Sanofi","keywords":"Pembrolizumab; Aflibercept; Medicine; Oncology; Internal medicine; Cancer; Bevacizumab; Immunotherapy; Chemotherapy","authors":[{"name":"Kevin Tyan","is_ca":false},{"name":"Osama E. Rahma","is_ca":false},{"name":"Anita Giobbie‐Hurder","is_ca":false},{"name":"Andrew S. Brohl","is_ca":false},{"name":"Philippe L. Bédard","is_ca":true},{"name":"Daniel J. Renouf","is_ca":false},{"name":"Elad Sharon","is_ca":false},{"name":"Howard Streicher","is_ca":false},{"name":"Emma Hathaway","is_ca":false},{"name":"Rachel Cunningham","is_ca":false},{"name":"Michael P. Manos","is_ca":false},{"name":"Mariano Severgnini","is_ca":false},{"name":"Scott J. Rodig","is_ca":false},{"name":"F. Stephen Hodi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01062840677381271,"gpt":0.2660235208790911,"spread":0.2553951141052784,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008001628,0.0009354826,0.001046233,0.0002901141,0.0003939339,0.0007303398,0.0005610732,0.0008701373,0.005015036],"category_scores_gemma":[0.0003875409,0.0004314912,0.001075358,0.0002516058,0.0005964288,0.0005185911,0.0002333458,0.002447977,0.0009279061],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00128684,"about_ca_system_score_gemma":0.001831591,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001869465,"about_ca_topic_score_gemma":0.004911193,"domain_scores_codex":[0.9997701,0.00008810863,0.00001386193,0.00003877107,0.0000236154,0.00006563395],"domain_scores_gemma":[0.9997358,0.00003090103,0.00003107925,0.00001211471,0.00001756108,0.0001725277],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7646522,0.05324489,0.009236126,0.0008807236,0.001344179,0.0003744193,0.0003030828,0.002463848,0.05589086,0.000460154,0.008600445,0.1025491],"study_design_scores_gemma":[0.6381229,0.337227,0.01380656,0.00003797859,0.0004534923,0.0002328822,0.00007631068,0.001105542,0.003410978,0.0002385449,0.005263592,0.00002423751],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9877089,0.002187852,0.0003332791,0.001048011,0.0002486979,0.003348371,0.001279573,0.00006079662,0.003784544],"genre_scores_gemma":[0.988709,0.00155013,0.001185741,0.001247017,0.0002084312,0.001964445,0.002226315,0.00001507977,0.002893908],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005015036,"threshold_uncertainty_score":0.01677698,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388042546","doi":"10.1136/jitc-2023-sitc2023.0601","title":"601 Identification of non-squamous NSCLC molecular subtypes and association with outcomes in the phase 3 IMpower150 study of 1L atezolizumab ± bevacizumab + carboplatin-paclitaxel in metastatic NSCLC","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Carboplatin; Atezolizumab; Bevacizumab; Medicine; Internal medicine; Paclitaxel; Oncology; Population; Chemotherapy; Cancer research; Cancer; Immunotherapy; Cisplatin; Nivolumab","authors":[{"name":"Tianshi Lü","is_ca":false},{"name":"Mark A. Socinski","is_ca":false},{"name":"Martin Reck","is_ca":false},{"name":"Howard West","is_ca":false},{"name":"Federico Cappuzzo","is_ca":false},{"name":"Fabrice Barlési","is_ca":false},{"name":"Robert M. Jotte","is_ca":false},{"name":"Sören Müller","is_ca":false},{"name":"Habib Hamidi","is_ca":false},{"name":"Assaf Amitai","is_ca":false},{"name":"Hartmut Koeppen","is_ca":false},{"name":"David S. Shames","is_ca":false},{"name":"Marcus Ballinger","is_ca":false},{"name":"Aditi Qamra","is_ca":true},{"name":"Minu K. Srivastava","is_ca":false},{"name":"Barzin Y. Nabet","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0100293777047789,"gpt":0.2723889858369495,"spread":0.2623596081321706,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001059828,0.0002985655,0.0005289234,0.0002105138,0.0002157249,0.0005471684,0.0003868413,0.0003656359,0.001642902],"category_scores_gemma":[0.0007595627,0.0003024617,0.0006719297,0.0002157539,0.0002592072,0.0002286052,0.000296181,0.0007284613,0.0002793233],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000323879,"about_ca_system_score_gemma":0.0004590643,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006775699,"about_ca_topic_score_gemma":0.001636785,"domain_scores_codex":[0.9996781,0.0001259121,0.00002483845,0.00006312904,0.00006540317,0.00004258642],"domain_scores_gemma":[0.9995992,0.00007532685,0.0001149358,0.00005433699,0.00003993428,0.0001162527],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.336529,0.008161561,0.4975393,0.0004956985,0.002333528,0.0002828977,0.0003273319,0.001031935,0.07470684,0.0001945052,0.003554801,0.0748426],"study_design_scores_gemma":[0.0219841,0.05648838,0.9065037,0.0000346395,0.001420492,0.000484003,0.00009936454,0.002057991,0.007851298,0.0001525907,0.002894549,0.00002875391],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987593,0.000355039,0.00009257285,0.00003742754,0.000007007549,0.00009156077,0.0003593934,0.000007825407,0.0002899737],"genre_scores_gemma":[0.9972313,0.0001408223,0.0002706426,0.0001486909,0.00002142715,0.0001411516,0.001530488,0.000006606496,0.000508928],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001642902,"threshold_uncertainty_score":0.005604982,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308407496","doi":"10.1136/jitc-2022-sitc2022.1071","title":"1071 Autologous tumor cell immunotherapeutic platform induces stress-correlated immunogenic cell death leading to immune activation within the draining lymph nodes","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Flow cytometry; Immunophenotyping; Cancer research; Immune system; Programmed cell death; Medicine; Apoptosis; Chemistry; Immunology","authors":[{"name":"Christopher Cultrara","is_ca":false},{"name":"Kenneth W. Kirby","is_ca":false},{"name":"Essam Elrazaq","is_ca":false},{"name":"Christopher Uhl","is_ca":false},{"name":"Amelia Zellander","is_ca":false},{"name":"Lorenzo Galluzzi","is_ca":false},{"name":"Mark A. Exley","is_ca":false},{"name":"Jenny Zilberberg","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02217041544240454,"gpt":0.2453659956535131,"spread":0.2231955802111086,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106071,0.0002566149,0.0001811339,0.0001091801,0.0001211457,0.0002562274,0.0001785935,0.0002416472,0.004025957],"category_scores_gemma":[0.00005276708,0.0001120721,0.0001449033,0.0001005509,0.0001935543,0.0001384724,0.0001378914,0.0005913486,0.0008284032],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002468271,"about_ca_system_score_gemma":0.0002544146,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005076758,"about_ca_topic_score_gemma":0.0006567915,"domain_scores_codex":[0.9998631,0.0000165506,0.000008093874,0.00003093694,0.0000417431,0.00003954464],"domain_scores_gemma":[0.9999691,0.000004615998,0.000008328851,0.000005136764,0.000003988467,0.000008787068],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006249321,0.0001741203,0.0004664623,0.00005301191,0.000007397999,0.00004567594,0.0000230753,0.0001620453,0.9936787,0.0002535171,0.0006610138,0.003850069],"study_design_scores_gemma":[0.0001253875,0.001718899,0.004386203,0.000006214812,0.00001423444,0.0003104369,0.00003485335,0.001454428,0.9876694,0.00009002132,0.004186134,0.000003722852],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906432,0.0006469828,0.00300668,0.000141721,0.0000671877,0.0001029169,0.0008725082,0.0001874412,0.004331488],"genre_scores_gemma":[0.9929598,0.0002930444,0.002355681,0.0001297457,0.000012994,0.0001174401,0.001052942,0.00002479515,0.003053642],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004025957,"threshold_uncertainty_score":0.01346821,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3101543312","doi":"10.1136/jitc-2020-sitc2020.0727","title":"727 Increased serum levels of EBI3 are associated with poor outcome in hepatocellular carcinoma patients and SRF388, a first-in-class IL-27 blocking antibody, inhibits the growth of murine liver tumors","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"TIGIT; Cancer research; Antibody; Cytokine; Hepatocellular carcinoma; Proinflammatory cytokine; Tumor microenvironment; Immune system; Biology; Medicine; Molecular biology; Immunology; T cell; Inflammation","authors":[{"name":"Matthew Rausch","is_ca":false},{"name":"Devapregasan Moodley","is_ca":false},{"name":"Marisa O. Peluso","is_ca":false},{"name":"Secil Koseoglu","is_ca":false},{"name":"Jing Hua","is_ca":false},{"name":"Gege Tan","is_ca":false},{"name":"Ricard Masia","is_ca":false},{"name":"Benjamin Lee","is_ca":false},{"name":"Isabelle Cousineau","is_ca":true},{"name":"Simon Turcotte","is_ca":true},{"name":"John Stagg","is_ca":true},{"name":"Vito J. Palombella","is_ca":false},{"name":"Pamela M. Holland","is_ca":false},{"name":"Jonathan A. Hill","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02249317592307051,"gpt":0.2240064407249474,"spread":0.2015132648018769,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001192617,0.0001844636,0.0002323432,0.0003211214,0.0001903683,0.0001887327,0.00008486322,0.0002171635,0.001217569],"category_scores_gemma":[0.0001855715,0.0001098531,0.0001934558,0.0002530997,0.0001332751,0.00009057634,0.0001122357,0.0002840165,0.0002122736],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001617594,"about_ca_system_score_gemma":0.0001536494,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00106315,"about_ca_topic_score_gemma":0.001395767,"domain_scores_codex":[0.9999509,0.000007913147,0.000004413727,0.00001101995,0.000009385272,0.0000163379],"domain_scores_gemma":[0.9998509,0.00001874844,0.00004742779,0.000008522242,0.00001321487,0.00006114466],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006159889,0.0002737996,0.942531,0.00004275343,0.0001346595,0.0007019446,0.00006701785,0.0001291015,0.04290211,0.00004062114,0.000570335,0.006446803],"study_design_scores_gemma":[0.00005093504,0.0005174961,0.9949704,0.000004175686,0.00004421229,0.0009071125,0.0000584702,0.0003288173,0.002636208,0.0000311531,0.00044676,0.000004233241],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991508,0.0001935388,0.00007013154,0.00003021111,0.00000424665,0.000006049492,0.0001742132,0.000008807081,0.0003620917],"genre_scores_gemma":[0.9991953,0.0000659586,0.00006657738,0.00002287105,0.000006502211,0.000009723562,0.0003514038,0.000002096456,0.0002795535],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001217569,"threshold_uncertainty_score":0.004073203,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388048274","doi":"10.1136/jitc-2023-sitc2023.0277","title":"277 SynNotch-CAR T cells demonstrate potent anti-tumor efficacy in a preclinical immunocompetent mouse model for glioblastoma","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Cancer research; Glioma; Immunotherapy; Chimeric antigen receptor; Tumor microenvironment; Flow cytometry; Immune system; Epidermal growth factor receptor; Antigen; Cytotoxic T cell; Brain tumor; Biology; Immunology; Medicine; Receptor; Pathology; Internal medicine; In vitro","authors":[{"name":"Senthilnath Lakshmanachetty","is_ca":false},{"name":"Milos Simic","is_ca":false},{"name":"Payal Watchmaker","is_ca":false},{"name":"Akane Yamamichi","is_ca":false},{"name":"Tiffany Chen","is_ca":false},{"name":"Su Phyu","is_ca":false},{"name":"Takahide Nejo","is_ca":false},{"name":"Chanelle Shepherd","is_ca":false},{"name":"Jason Duecker","is_ca":false},{"name":"Yuan Wang","is_ca":false},{"name":"Olga G. Troyanskaya","is_ca":false},{"name":"Lia Cardarelli","is_ca":true},{"name":"Sachdev S. Sidhu","is_ca":true},{"name":"Wendell A. Lim","is_ca":false},{"name":"Hideho Okada","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04880684535185395,"gpt":0.3212046304507716,"spread":0.2723977850989177,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002850354,0.0008918318,0.0004526104,0.0005932152,0.000172959,0.0003396466,0.0003821813,0.0006743068,0.001841175],"category_scores_gemma":[0.000113695,0.0002654706,0.0004554298,0.000220518,0.0003211094,0.000354428,0.0001414687,0.001495068,0.0007522388],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004294303,"about_ca_system_score_gemma":0.0003470467,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001523698,"about_ca_topic_score_gemma":0.001758697,"domain_scores_codex":[0.9997069,0.00003589104,0.00003228043,0.00005785837,0.0000680513,0.00009895158],"domain_scores_gemma":[0.9998449,0.00002025769,0.00004651067,0.00002092573,0.00002196371,0.00004540968],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000481127,0.0003899744,0.0001083973,0.00004431732,0.000008956926,0.00006887561,0.00003563671,0.0002514886,0.9969165,0.0001810413,0.0002128822,0.001300962],"study_design_scores_gemma":[0.000077481,0.002354299,0.0009030725,0.00000719254,0.00001964387,0.0001558745,0.0000279075,0.001349463,0.9937542,0.00004625667,0.001298546,0.000006081324],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904099,0.0009409403,0.003704408,0.0002229838,0.0001124336,0.0001620984,0.001340916,0.0002989811,0.002807427],"genre_scores_gemma":[0.9883252,0.0008737819,0.003084674,0.0001821028,0.00003097666,0.000196616,0.00144004,0.00008790009,0.005778698],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001841175,"threshold_uncertainty_score":0.006159365,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388083490","doi":"10.1136/jitc-2023-sitc2023.0783","title":"783 Combined immunotherapy improves outcome for replication repair deficient (RRD) high-grade glioma failing anti-PD1 monotherapy: a report from the International RRD consortium","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Stand Up To Cancer","keywords":"Ipilimumab; Medicine; Nivolumab; Internal medicine; Immunotherapy; Progression-free survival; Oncology; Melanoma; Progressive disease; Chemotherapy; Cancer research; Cancer","authors":[{"name":"Anirban Das","is_ca":true},{"name":"Nicholas Fernandez","is_ca":true},{"name":"Adrian Levine","is_ca":true},{"name":"Vanessa Bianchi","is_ca":true},{"name":"Lucie Stengs","is_ca":true},{"name":"Melissa Edwards","is_ca":true},{"name":"Trevor J. Pugh","is_ca":true},{"name":"Derek S. Tsang","is_ca":true},{"name":"Birgit Ertl‐Wagner","is_ca":true},{"name":"Daniel A. Morgenstern","is_ca":true},{"name":"Cynthia Hawkins","is_ca":true},{"name":"Éric Bouffet","is_ca":true},{"name":"Uri Tabori","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03118325356358788,"gpt":0.293107385921724,"spread":0.2619241323581362,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001429046,0.0002979491,0.0003698288,0.0002634583,0.0002021622,0.0004980642,0.0002090084,0.0002210414,0.0004861724],"category_scores_gemma":[0.0008501646,0.0000552055,0.000495437,0.0003419968,0.0002489171,0.000193148,0.0002141796,0.000373283,0.0001475171],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005186811,"about_ca_system_score_gemma":0.0006502614,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001513752,"about_ca_topic_score_gemma":0.002210054,"domain_scores_codex":[0.9997236,0.00009339675,0.00003135436,0.00004726026,0.00005011712,0.00005417563],"domain_scores_gemma":[0.9995235,0.0001178332,0.0001126113,0.00007111047,0.00007987741,0.00009513435],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.038491,0.004790933,0.4128561,0.0006719975,0.001940655,0.001708016,0.0005849936,0.001304216,0.05267624,0.000267419,0.009128533,0.4755799],"study_design_scores_gemma":[0.005572238,0.06495434,0.8721603,0.0001661556,0.002334627,0.00469842,0.0004729683,0.001832273,0.03098404,0.0002206472,0.01652865,0.00007538967],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924143,0.004298791,0.0002684298,0.0003781607,0.00002020481,0.00009139287,0.0004738016,0.00002867492,0.002026173],"genre_scores_gemma":[0.9963136,0.001615961,0.0004089843,0.0002999278,0.00004683944,0.00005611836,0.0009614501,0.000009528913,0.0002875328],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001513752,"threshold_uncertainty_score":0.007557631,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388077811","doi":"10.1136/jitc-2023-sitc2023.0760","title":"760 Interim PK/PD, safety and efficacy data of monotherapy dose escalation of a phase 1/2 study with MDNA11 in patients with advanced solid tumors","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pharmacodynamics; Adverse effect; Pharmacokinetics; Internal medicine; Dosing; Toxicity; Response Evaluation Criteria in Solid Tumors; Melanoma; Gastroenterology; Oncology; Pharmacology; Phases of clinical research; Urology; Cancer research","authors":[{"name":"Minh D. To","is_ca":false},{"name":"Rosemina Merchant","is_ca":false},{"name":"Victoria Atkinson","is_ca":false},{"name":"Philippe L. Bédard","is_ca":true},{"name":"Warren Brenner","is_ca":false},{"name":"Melissa Coello","is_ca":false},{"name":"Jesús Fuentes‐Antrás","is_ca":true},{"name":"Carole L. Galligan","is_ca":false},{"name":"Charlotte Lemech","is_ca":false},{"name":"Peter Lloyd","is_ca":false},{"name":"Sudhir Madduri Karanam","is_ca":false},{"name":"Kim Margolin","is_ca":false},{"name":"Matthen Mathew","is_ca":false},{"name":"Amy Prawira","is_ca":false},{"name":"Sajeve Thomas","is_ca":false},{"name":"Przemyslaw Twardowski","is_ca":false},{"name":"Arash Yavari","is_ca":false},{"name":"Fahar Merchant","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02524647422427279,"gpt":0.3088298909247724,"spread":0.2835834167004996,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002222127,0.0007224621,0.001136904,0.0003414396,0.0003523101,0.0008114061,0.0005442833,0.0007159567,0.003270599],"category_scores_gemma":[0.001021261,0.0003664351,0.001185551,0.0003205564,0.0006827413,0.0005617191,0.0002362412,0.002210461,0.0009285163],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008546872,"about_ca_system_score_gemma":0.001411809,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006822915,"about_ca_topic_score_gemma":0.001607507,"domain_scores_codex":[0.9991647,0.0004452038,0.00006022558,0.000101518,0.00008759112,0.0001408312],"domain_scores_gemma":[0.9987716,0.0002617883,0.000236401,0.0001680039,0.0001012455,0.0004608795],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5617008,0.07832726,0.01453562,0.0005464294,0.001452125,0.0004538133,0.0004020387,0.009915027,0.1749326,0.0005235823,0.009798205,0.1474126],"study_design_scores_gemma":[0.1400653,0.8012547,0.02239488,0.00002963698,0.0004604205,0.0004707703,0.00005662866,0.002512004,0.02535662,0.000337398,0.007002704,0.00005894607],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912217,0.0008940906,0.0008586848,0.000316642,0.00007211145,0.001834487,0.002078463,0.00009307846,0.002630777],"genre_scores_gemma":[0.9858361,0.0005458301,0.002944514,0.0006395138,0.00009420612,0.001885131,0.004858711,0.00004735938,0.003148511],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003270599,"threshold_uncertainty_score":0.01175183,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308400784","doi":"10.1136/jitc-2022-sitc2022.1028","title":"1028 IL-12 and IL-27 upregulate CD39 expression on CD8<sup>+</sup> T-cells and differentially affect CD39<sup>+</sup>CD8<sup>+</sup> T-cell effector function","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Cytotoxic T cell; CD8; CD28; Biology; T cell; Molecular biology; IL-2 receptor; Tumor-infiltrating lymphocytes; Flow cytometry; Interleukin 21; Cancer research; Immune system; Cell biology; Chemistry; Immunology; In vitro; Biochemistry","authors":[{"name":"Lara Gerhardt","is_ca":true},{"name":"René Figueredo","is_ca":true},{"name":"Saman Maleki","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01338454817618056,"gpt":0.233697738298737,"spread":0.2203131901225564,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006666304,0.0002423599,0.0001816836,0.0001383126,0.00007802765,0.0002447041,0.0001047448,0.000236845,0.003737992],"category_scores_gemma":[0.00007287873,0.00008906301,0.0001508407,0.0001017129,0.0001642324,0.0001239836,0.0001050465,0.0005707899,0.001015649],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001146713,"about_ca_system_score_gemma":0.0001529219,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001515736,"about_ca_topic_score_gemma":0.0003382778,"domain_scores_codex":[0.9998499,0.00002325666,0.00001808198,0.0000227992,0.00003150676,0.00005440087],"domain_scores_gemma":[0.999934,0.00001163458,0.00001434495,0.00000709558,0.000006014503,0.00002706641],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008181819,0.0001665281,0.0004689615,0.00004764718,0.000003978826,0.0001298058,0.00001657043,0.00006297458,0.9959948,0.00008398409,0.0001431049,0.002063354],"study_design_scores_gemma":[0.000200206,0.002405565,0.01494605,0.00001718848,0.0000321664,0.0005399205,0.0001483472,0.001358945,0.9741439,0.0001599775,0.006037214,0.00001052672],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"other","genre_scores_codex":[0.9954497,0.0007502108,0.0007473565,0.0001122982,0.00006555219,0.00002695688,0.0003901351,0.00005134138,0.002406474],"genre_scores_gemma":[0.9932083,0.0004281187,0.001262496,0.0001381605,0.00002544178,0.00008371583,0.0006353411,0.00001763204,0.004200712],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.003737992,"threshold_uncertainty_score":0.01250482,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388047842","doi":"10.1136/jitc-2023-sitc2023.0544","title":"544 Coordinated blockade of TGF-β and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector memory responses","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research; EMD Serono","keywords":"Ovarian cancer; Cancer research; Immune system; Immunotherapy; Tumor microenvironment; Cytotoxic T cell; Cancer; Medicine; Immunology; Cytokine; Biology; Internal medicine","authors":[{"name":"Jacob Kment","is_ca":true},{"name":"Daniel Newsted","is_ca":true},{"name":"Stephanie Young","is_ca":true},{"name":"Michael Vermeulen","is_ca":true},{"name":"Andrew W. Craig","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03204473608297409,"gpt":0.3024263362297205,"spread":0.2703816001467464,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001345771,0.0003572415,0.0002951971,0.0002603882,0.0001446697,0.0002185344,0.0001878271,0.0002717535,0.001612071],"category_scores_gemma":[0.00005689147,0.0001210122,0.0002550538,0.000156515,0.0001754342,0.0001843838,0.0001317893,0.0008894781,0.0003652039],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002428162,"about_ca_system_score_gemma":0.0002724976,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009938177,"about_ca_topic_score_gemma":0.001903358,"domain_scores_codex":[0.9998727,0.00001324913,0.00001262614,0.00001800063,0.00002995675,0.00005350166],"domain_scores_gemma":[0.9999315,0.000005962369,0.00001838354,0.000007219395,0.000007351402,0.00002966703],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001444209,0.0005022223,0.0003737148,0.00007271434,0.00001189875,0.00005547728,0.00002885604,0.0002492371,0.9914601,0.00009766287,0.0004096104,0.005294225],"study_design_scores_gemma":[0.0001870917,0.005878713,0.004728551,0.00000868266,0.00003139541,0.0002245701,0.00004442215,0.001201826,0.9837137,0.00005216348,0.003922554,0.000006362483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937382,0.001042241,0.001435603,0.0001788102,0.00006382568,0.00009891522,0.001008356,0.000184832,0.002249104],"genre_scores_gemma":[0.9930791,0.000761427,0.001749719,0.0001258769,0.0000214701,0.0001412706,0.001012514,0.00002145669,0.003087066],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001612071,"threshold_uncertainty_score":0.005392909,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3113360743","doi":"10.1136/jitc-2020-sitc2020.0020","title":"20 Quantification of sBCMA in human plasma using a high-throughput mass spectrometry workflow for exploratory, CAP/CLIA or regulated studies","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Caprion (Canada)","funders":"","keywords":"Chemistry; Chromatography; Mass spectrometry; Peptide; Selected reaction monitoring; Tandem mass spectrometry; Biochemistry","authors":[{"name":"Luca Genovesi","is_ca":true},{"name":"Michael Schirm","is_ca":true},{"name":"Gwënaël Pottiez","is_ca":true},{"name":"Rudolf Guilbaud","is_ca":true},{"name":"Lorella Di Donato","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1380512454315843,"gpt":0.3556764921383321,"spread":0.2176252467067478,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002945168,0.001272423,0.0006563569,0.00158592,0.0009020594,0.001290389,0.001047984,0.001370466,0.002465077],"category_scores_gemma":[0.001845887,0.0005177252,0.0009221226,0.0009070064,0.0006992172,0.0006624483,0.00102682,0.001164056,0.002717534],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009587041,"about_ca_system_score_gemma":0.002102663,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001562433,"about_ca_topic_score_gemma":0.002208314,"domain_scores_codex":[0.9977019,0.0003559195,0.0001419679,0.0006424845,0.001004444,0.0001531898],"domain_scores_gemma":[0.9991548,0.0001668058,0.000158904,0.0001233818,0.0003222227,0.00007397409],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000328571,0.0001750625,0.001785071,0.0003363558,0.00009313934,0.0002100055,0.0001376145,0.000649622,0.9732737,0.0009283548,0.002289338,0.01979317],"study_design_scores_gemma":[0.00006061976,0.0005254808,0.006096623,0.00008454617,0.00007185085,0.0008781955,0.00007076605,0.01664299,0.9511995,0.001052985,0.02323981,0.00007652115],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"methods","genre_gemma":"methods","genre_scores_codex":[0.2716254,0.006614481,0.6793558,0.00144334,0.0005380817,0.003626352,0.01052814,0.01371156,0.0125568],"genre_scores_gemma":[0.3616995,0.003519471,0.6114476,0.001985876,0.0002147264,0.004469522,0.007459661,0.0008769981,0.008326664],"genre_candidate":"methods","genre_consensus":"methods","teacher_disagreement_score":0.002945168,"threshold_uncertainty_score":0.01557571,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3113081454","doi":"10.1136/jitc-2020-sitc2020.0265","title":"265 Phase 1b study of avelumab + M9241 (NHS-IL12) in patients with advanced solid tumors: interim analysis results from a urothelial carcinoma (UC) dose-expansion cohort","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Interim analysis; Interim; Avelumab; Cohort; Urothelial carcinoma; Oncology; Medicine; Internal medicine; Political science; Bladder cancer; Immunotherapy; Cancer; Clinical trial","authors":[{"name":"Jean‐Laurent Deville","is_ca":false},{"name":"Alain Ravaud","is_ca":false},{"name":"Marco Maruzzo","is_ca":false},{"name":"Theodore Stewart Gourdin","is_ca":false},{"name":"Michele Maio","is_ca":false},{"name":"Luc Dirix","is_ca":false},{"name":"XiaoZhe Wang","is_ca":false},{"name":"Yulia Vugmeyster","is_ca":false},{"name":"Frank Beier","is_ca":false},{"name":"Jeorg Seebeck","is_ca":false},{"name":"Sarah Chennoufi","is_ca":false},{"name":"James L. Gulley","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01670594694064256,"gpt":0.2663233916641324,"spread":0.2496174447234899,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002538636,0.001295018,0.001547286,0.0003185652,0.0003857496,0.001045623,0.0006074451,0.0008142867,0.003354909],"category_scores_gemma":[0.0009485462,0.0004812943,0.002166241,0.0003041728,0.0005204072,0.0005182272,0.0003414166,0.002481664,0.001063169],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008408265,"about_ca_system_score_gemma":0.00138332,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008639062,"about_ca_topic_score_gemma":0.001668793,"domain_scores_codex":[0.9993172,0.0003450237,0.00002816182,0.00008916279,0.00007945351,0.0001410293],"domain_scores_gemma":[0.9991903,0.0001250863,0.000168171,0.0001221756,0.0000652689,0.0003289966],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8128331,0.02990445,0.02049787,0.0003986838,0.002821198,0.00024585,0.0001809102,0.005994941,0.05151341,0.0002412995,0.008915768,0.0664525],"study_design_scores_gemma":[0.3418844,0.5628791,0.06225219,0.00004923086,0.002207213,0.0005742186,0.0001054167,0.004092428,0.01543354,0.0004529816,0.009993643,0.00007557538],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878512,0.001379398,0.001052522,0.0003710234,0.000110538,0.001899307,0.004826262,0.0001711251,0.002338673],"genre_scores_gemma":[0.974312,0.0008152291,0.003118678,0.0009086042,0.0001155415,0.002400352,0.01416808,0.00009467556,0.004066854],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003354909,"threshold_uncertainty_score":0.01342577,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388048048","doi":"10.1136/jitc-2023-sitc2023.0582","title":"582 Analysis of the HR+/HER2- breast cancer tumor microenvironment following immune priming with pelareorep and atezolizumab using imaging mass cytometry – Results from the AWARE-1 trial","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Atezolizumab; Medicine; Tumor microenvironment; Breast cancer; Immune system; Oncology; Internal medicine; Antibody; Triple-negative breast cancer; Cancer; Cancer research; Immunotherapy; Immunology; Nivolumab","authors":[{"name":"Julian Olea","is_ca":false},{"name":"Homa Dadrastoussi","is_ca":false},{"name":"Eduardo Fernandez Hernandez","is_ca":false},{"name":"Hugo Lara Martinez","is_ca":false},{"name":"Kaijin Wu","is_ca":false},{"name":"Houra Loghmani","is_ca":true},{"name":"Thomas Heineman","is_ca":false},{"name":"Richard Trauger","is_ca":false},{"name":"Matt Coffey","is_ca":true},{"name":"Fernando Salvador","is_ca":false},{"name":"Joaquín Gavilá","is_ca":false},{"name":"Tomás Pascual","is_ca":false},{"name":"Luís Manso","is_ca":false},{"name":"Aleix Prat","is_ca":false},{"name":"Akil Merchant","is_ca":false},{"name":"Kevin R. Kelly","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01259663640010753,"gpt":0.2596904684011493,"spread":0.2470938320010418,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007645444,0.0003241496,0.0005594307,0.0001781697,0.0001571215,0.0005822628,0.0002599251,0.0004922051,0.001497119],"category_scores_gemma":[0.0003724209,0.0002056165,0.0003873145,0.0001437585,0.0002361928,0.0002961787,0.0001751283,0.0007389541,0.0003757193],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003065501,"about_ca_system_score_gemma":0.0002826532,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002909071,"about_ca_topic_score_gemma":0.0005287533,"domain_scores_codex":[0.999718,0.00008876373,0.00001846602,0.00006614338,0.00006055626,0.00004803212],"domain_scores_gemma":[0.9997876,0.00004546654,0.00005194923,0.00003356414,0.00002343074,0.00005793498],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.2631359,0.01837875,0.0934913,0.0005281857,0.0009673962,0.0003078244,0.0002537753,0.002499228,0.4449081,0.0003048585,0.004533242,0.1706914],"study_design_scores_gemma":[0.05579307,0.3069425,0.4143572,0.0000512558,0.00215409,0.001175506,0.0002835807,0.005071896,0.2009741,0.0005771394,0.0125223,0.00009739795],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965719,0.0009677231,0.0002992124,0.00008170368,0.0000301346,0.0002940119,0.0004511069,0.00002558864,0.001278527],"genre_scores_gemma":[0.9940445,0.0005566978,0.0009937865,0.0003255214,0.00008018953,0.000474149,0.002167879,0.00001654704,0.001340706],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001497119,"threshold_uncertainty_score":0.00500834,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388047658","doi":"10.1136/jitc-2023-sitc2023.0654","title":"654 A phase I/II trial investigating safety and efficacy of autologous TAC01-HER2 in relapsed or refractory solid tumors","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cytokine release syndrome; Chimeric antigen receptor; Adverse effect; Refractory (planetary science); Internal medicine; Pharmacokinetics; Immunotherapy; Leukapheresis; T cell; Chemotherapy; Oncology; Gastroenterology; Immunology; Immune system; Cancer; Stem cell","authors":[{"name":"Daniel J. Olson","is_ca":false},{"name":"Ecaterina E. Dumbrava","is_ca":false},{"name":"Mridula George","is_ca":false},{"name":"Sam Saibil","is_ca":true},{"name":"Marcus O. Butler","is_ca":true},{"name":"Antonio Giordano","is_ca":false},{"name":"Brooke Pieke","is_ca":false},{"name":"Miriam Gavriliuc","is_ca":false},{"name":"Emily Lichtenstein","is_ca":false},{"name":"Jill Geisberger","is_ca":true},{"name":"Maria Apostolopoulou","is_ca":false},{"name":"Kara Moss","is_ca":false},{"name":"D’Arcy Kirkwood","is_ca":false},{"name":"Salina Dang","is_ca":false},{"name":"Deyaa Adib","is_ca":false},{"name":"Benjamin L. Schlechter","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0445197377225094,"gpt":0.3424634879703385,"spread":0.2979437502478291,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001259919,0.0008492024,0.0008601312,0.0003176032,0.0003645744,0.0006279638,0.0005904366,0.0008152665,0.005233837],"category_scores_gemma":[0.0004592938,0.0003293357,0.0008644147,0.000271242,0.0006021079,0.0003729842,0.0002072373,0.00203414,0.0009908547],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007367258,"about_ca_system_score_gemma":0.001834628,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001589578,"about_ca_topic_score_gemma":0.002538452,"domain_scores_codex":[0.9997047,0.0001409749,0.00001395212,0.00004038963,0.00003040048,0.00006961851],"domain_scores_gemma":[0.9995747,0.00006686435,0.00005793983,0.00004034319,0.00002904592,0.0002310994],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.713187,0.09907936,0.006565719,0.000632363,0.001072207,0.0004771843,0.0002307695,0.003205817,0.07543354,0.0005961795,0.01003834,0.08948157],"study_design_scores_gemma":[0.5176327,0.4626455,0.005896317,0.00002971003,0.0003028618,0.0001961251,0.00004408519,0.00161663,0.00784044,0.0003346781,0.003441915,0.00001897585],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897323,0.000870352,0.0005143859,0.0004354684,0.000124735,0.00349153,0.001493128,0.00008404299,0.003254078],"genre_scores_gemma":[0.9831017,0.000950674,0.001822335,0.001366165,0.0001856535,0.003098484,0.004004583,0.00003815133,0.00543237],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005233837,"threshold_uncertainty_score":0.01750886,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388071235","doi":"10.1136/jitc-2023-sitc2023.1490","title":"1490 High-plex co-detection of RNA and protein to explore tumor-immune interactions utilizing RNAscope with imaging mass cytometry","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Mass cytometry; RNA; Biology; Molecular biology; Computational biology; Phenotype; Biochemistry","authors":[{"name":"James Pemberton","is_ca":true},{"name":"Smriti Kala","is_ca":true},{"name":"Anushka Dikshit","is_ca":false},{"name":"Clinton Hupple","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01845165894724315,"gpt":0.2781303994629118,"spread":0.2596787405156686,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001259067,0.0008373485,0.0004131757,0.001242208,0.0003336962,0.001095843,0.0006738603,0.0009821871,0.01090315],"category_scores_gemma":[0.000493096,0.0003440114,0.0003860205,0.0004218277,0.000412718,0.0005979919,0.0005963797,0.001154112,0.004198889],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005157145,"about_ca_system_score_gemma":0.0004339141,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002261058,"about_ca_topic_score_gemma":0.0006794047,"domain_scores_codex":[0.9990237,0.0001884971,0.00005750691,0.0002838412,0.000383831,0.00006268432],"domain_scores_gemma":[0.999651,0.0001526594,0.0000346762,0.00004331372,0.00007814089,0.00004018675],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00004384607,0.00003515613,0.000275949,0.00006041313,0.000009964303,0.00004433796,0.00003052647,0.0002007089,0.9903489,0.0005941875,0.0007039297,0.007652202],"study_design_scores_gemma":[0.00001398212,0.00007940037,0.001476774,0.00001362346,0.0000119869,0.0001794726,0.00001856294,0.01467545,0.9761527,0.0003389377,0.00702194,0.00001720593],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.2097214,0.001906314,0.7594568,0.0005183034,0.0003409994,0.0006562907,0.002166409,0.009319396,0.01591414],"genre_scores_gemma":[0.2896571,0.001804035,0.6729771,0.0008222902,0.0001651213,0.002310693,0.004255496,0.0008286071,0.02717968],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01090315,"threshold_uncertainty_score":0.03647465,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3214232282","doi":"10.1136/jitc-2021-sitc2021.353","title":"353 Identification of potential response predictors to maveropepimut-S (DPX-Survivac), a novel T cell activating immunotherapy, in patients with advanced recurrent ovarian cancer","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Alberta Health Services; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Immunotherapy; CD8; Immune system; T cell; Antigen; Ovarian cancer; Oncology; Immunohistochemistry; Cancer research; Cancer; Cyclophosphamide; Internal medicine; Chemotherapy; Immunology","authors":[{"name":"Oliver Dorigo","is_ca":false},{"name":"Walead Ebrahimizadeh","is_ca":false},{"name":"Barry Kennedy","is_ca":false},{"name":"Lisa D. MacDonald","is_ca":false},{"name":"Stephan Fiset","is_ca":false},{"name":"Jeannine Villella","is_ca":false},{"name":"O D L U Z H N E V S K A Y A","is_ca":true},{"name":"Tanja Pejović","is_ca":false},{"name":"Prafull Ghatage","is_ca":true},{"name":"Diane Provencher","is_ca":false},{"name":"Yogesh Bramhecha","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.00683929153160976,"gpt":0.2201043896604499,"spread":0.2132650981288401,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000189653,0.000134399,0.0002616163,0.0002820118,0.000126203,0.0002489801,0.00009349147,0.0002412912,0.0006893559],"category_scores_gemma":[0.0003249736,0.00007250303,0.0001727182,0.0002332059,0.0001078242,0.0001139463,0.0000955054,0.0002207978,0.0001469614],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000159348,"about_ca_system_score_gemma":0.0001466851,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006704924,"about_ca_topic_score_gemma":0.0008209003,"domain_scores_codex":[0.9999329,0.000014763,0.000005842384,0.00001797255,0.00001128591,0.00001719199],"domain_scores_gemma":[0.9998726,0.00003172814,0.000035485,0.000007611798,0.00001704774,0.00003556878],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005011799,0.0003289449,0.9312537,0.00006012446,0.00007147744,0.0004476868,0.0001601691,0.0004019708,0.03559855,0.0000338116,0.0005267073,0.02610499],"study_design_scores_gemma":[0.0001146148,0.003673553,0.9863667,0.000008738219,0.00009262539,0.0009190467,0.0001353743,0.002103631,0.004958237,0.00006838488,0.001550871,0.000008350202],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9992989,0.0002713256,0.00006804877,0.00001869504,0.000003285539,0.00001341852,0.0001067475,0.000004650467,0.000214857],"genre_scores_gemma":[0.9994734,0.00006462173,0.00009579317,0.00002356543,0.0000074454,0.00001263095,0.0002044892,0.000001116534,0.0001170364],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0006893559,"threshold_uncertainty_score":0.002306104,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4416074415","doi":"10.1136/jitc-2025-sitc2025.0106","title":"106 Spatial multi-omic characterization of tumor microenvironment heterogeneity in hepatocellular carcinoma","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Tumor microenvironment; Hepatocellular carcinoma; Tumor heterogeneity; Tumor cells; Cancer","authors":[{"name":"Atefeh Khakpoor","is_ca":false},{"name":"Qanber Raza","is_ca":true},{"name":"Dina Kazemi","is_ca":false},{"name":"Erin Coll","is_ca":false},{"name":"Liang Lim","is_ca":true},{"name":"Nick Zabinyakov","is_ca":false},{"name":"Liang Qiao","is_ca":false},{"name":"Anna Di Bartolomeo","is_ca":false},{"name":"Helen M. McGuire","is_ca":false},{"name":"Jacob George","is_ca":false},{"name":"Ankur Sharma","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02886582805946386,"gpt":0.2299068720586562,"spread":0.2010410439991923,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002001169,0.0002242983,0.0002112799,0.00115879,0.0002381022,0.0005462382,0.0001056226,0.0002446768,0.002070533],"category_scores_gemma":[0.0001985881,0.0001610472,0.0002087348,0.0007425196,0.0001355439,0.0001982912,0.0002648621,0.000311824,0.0007526976],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002381715,"about_ca_system_score_gemma":0.0001935144,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001578835,"about_ca_topic_score_gemma":0.002623003,"domain_scores_codex":[0.9998487,0.00001371848,0.00001014655,0.00003802551,0.00005661803,0.00003276625],"domain_scores_gemma":[0.999889,0.00002027426,0.00002033991,0.00001715375,0.00003575872,0.00001744673],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.00006832738,0.00001117168,0.003187312,0.00005452096,0.00001667348,0.00005745358,0.00001830506,0.000115068,0.9930641,0.00006427173,0.0002327385,0.003110178],"study_design_scores_gemma":[0.00001535103,0.0001162521,0.2159352,0.00002763795,0.0001023539,0.001183219,0.000361547,0.008355188,0.7653007,0.0002511982,0.008320778,0.00003052475],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9648817,0.002767993,0.02180976,0.0003520723,0.00005005872,0.00005010563,0.005666182,0.000488496,0.003933611],"genre_scores_gemma":[0.961567,0.001141102,0.02602092,0.0002084284,0.00002922122,0.00007294205,0.0069928,0.0001365554,0.003831002],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002070533,"threshold_uncertainty_score":0.006926656,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388048122","doi":"10.1136/jitc-2023-sitc2023.0738","title":"738 A phase 1/2 study investigating the safety and efficacy of autologous TAC T cells in subjects with unresectable, locally advanced or metastatic claudin 18.2+ solid tumors","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Immunotherapy; Leukapheresis; Chimeric antigen receptor; Cancer research; Radioimmunotherapy; Stem cell; Immunology; Immune system; Antibody; Biology; CD34","authors":[{"name":"Daniel J. Olson","is_ca":false},{"name":"Ecaterina E. Dumbrava","is_ca":false},{"name":"Sam Saibil","is_ca":true},{"name":"Martin Gutierez","is_ca":false},{"name":"Syma Iqbal","is_ca":false},{"name":"Davendra Sohal","is_ca":false},{"name":"Maria Apostolopoulou","is_ca":false},{"name":"Kara Moss","is_ca":false},{"name":"Deyaa Adib","is_ca":false},{"name":"Benjamin L. Schlechter","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03770694743003553,"gpt":0.3355257030615537,"spread":0.2978187556315182,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001264576,0.001071699,0.00128975,0.0003189049,0.0004798186,0.0006466552,0.0006037928,0.001066363,0.004925877],"category_scores_gemma":[0.0004736913,0.0004351817,0.0009904238,0.0002584585,0.0007681729,0.000492639,0.0001824456,0.002252894,0.001063779],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006799449,"about_ca_system_score_gemma":0.001813057,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001332941,"about_ca_topic_score_gemma":0.002329307,"domain_scores_codex":[0.9996537,0.0001425992,0.00001470635,0.00006301238,0.00003668216,0.00008934792],"domain_scores_gemma":[0.9995009,0.00007492206,0.00007234867,0.00004433397,0.00005415308,0.0002534965],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5465207,0.2030859,0.007923618,0.0008074374,0.000826515,0.0007244151,0.0003730515,0.002107296,0.1544756,0.0004442706,0.008071602,0.07463969],"study_design_scores_gemma":[0.1210278,0.8638402,0.004941673,0.00001462077,0.0002433411,0.0002024894,0.00005152919,0.0006628783,0.006134918,0.000139171,0.002724983,0.00001650955],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890431,0.0007640322,0.0009835535,0.0003111175,0.0001385925,0.005190769,0.001391572,0.00009868419,0.002078648],"genre_scores_gemma":[0.9820474,0.0009226039,0.002446706,0.001080477,0.000230193,0.005413456,0.00215311,0.00004285949,0.005663169],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004925877,"threshold_uncertainty_score":0.01647872,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308378595","doi":"10.1136/jitc-2022-sitc2022.0052","title":"52 Digital pathology training effectiveness for the evaluation of PD-L1 expression in multiple tumor indications","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Cancer Institute; Government of Ontario; Ontario Institute for Cancer Research","keywords":"Digital pathology; Concordance; Medicine; Digital image analysis; Test (biology); Medical physics; Artificial intelligence; Computer science; Pathology; Computer vision; Internal medicine","authors":[{"name":"Jennifer G. Robinson","is_ca":false},{"name":"Edward Manna","is_ca":false},{"name":"Charlotte Roach","is_ca":false},{"name":"Ryan Marczak","is_ca":false},{"name":"Arkendra De","is_ca":false},{"name":"Joshua Littrell","is_ca":false},{"name":"Micki Adams","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04122079206106776,"gpt":0.3111353124665198,"spread":0.2699145204054521,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01044438,0.0003908363,0.0003232707,0.001108416,0.0003869981,0.001038332,0.0005250616,0.0004081599,0.00873376],"category_scores_gemma":[0.01965279,0.0002507723,0.0007140124,0.0004591518,0.0005070799,0.0007228144,0.001086574,0.0003415198,0.001465686],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007727168,"about_ca_system_score_gemma":0.0004185845,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001642455,"about_ca_topic_score_gemma":0.003074804,"domain_scores_codex":[0.9934316,0.002715238,0.0005602606,0.001173154,0.00178882,0.0003309544],"domain_scores_gemma":[0.9804195,0.01257759,0.002701703,0.00153941,0.001826061,0.0009358657],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01060127,0.00197356,0.4850702,0.0005643709,0.0003481937,0.0001729567,0.0009084112,0.003217787,0.03710774,0.0003427918,0.004823613,0.4548691],"study_design_scores_gemma":[0.0001142253,0.006196847,0.9327489,0.0001171964,0.000397365,0.0004777843,0.0004373135,0.01401937,0.03978411,0.0001842682,0.005447133,0.00007555977],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9828468,0.0005806861,0.005884757,0.0002045028,0.00008028816,0.0002843991,0.0004949208,0.0003270789,0.009296525],"genre_scores_gemma":[0.9895865,0.0001639549,0.00729078,0.0000726581,0.00003318298,0.0001684991,0.0004950806,0.00005796937,0.002131484],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01044438,"threshold_uncertainty_score":0.0552358,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388072202","doi":"10.1136/jitc-2023-sitc2023.0594","title":"594 SQZ-PBMC-HPV-101: Increased overall survival in a subset of patients with recurrent, locally advanced, or metastatic HPV16<sup>+</sup>tumors treated with cell-based vaccine, SQZ-PBMC-HPV","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Peripheral blood mononuclear cell; Medicine; Antigen; CD8; T cell; Immunotherapy; Immunology; Immune system; Internal medicine; Oncology; Biology","authors":[{"name":"Antonio Jimeno","is_ca":false},{"name":"Wade T. Iams","is_ca":false},{"name":"Jong‐Chul Park","is_ca":false},{"name":"Udo Holtick","is_ca":false},{"name":"Michael S. Gordon","is_ca":false},{"name":"Kerry J. Rodabaugh","is_ca":false},{"name":"Neesha C. Dhani","is_ca":true},{"name":"Matthew H. Taylor","is_ca":false},{"name":"Eric Duvall","is_ca":false},{"name":"Julia Jennings","is_ca":false},{"name":"Nathan R. Miselis","is_ca":false},{"name":"Scott Loughhead","is_ca":false},{"name":"Marshelle Warren","is_ca":false},{"name":"Howard Bernstein","is_ca":false},{"name":"Joaquina Baranda","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01966662828364165,"gpt":0.2677507664605239,"spread":0.2480841381768823,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001948321,0.0001774574,0.00036703,0.0001291424,0.0001333588,0.0002512694,0.00009893191,0.0002186739,0.001429731],"category_scores_gemma":[0.0001840887,0.00008012712,0.0002314886,0.0001067967,0.0001466767,0.0001463844,0.0001282621,0.0002532945,0.0002423872],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002017584,"about_ca_system_score_gemma":0.0001462347,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002423717,"about_ca_topic_score_gemma":0.0004145591,"domain_scores_codex":[0.9999107,0.00002009094,0.00000609272,0.00002974214,0.00001320745,0.00002019074],"domain_scores_gemma":[0.9998817,0.00002526082,0.0000226248,0.000009757115,0.00001008991,0.00005047051],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.04235015,0.001724952,0.7856842,0.0001414949,0.0002252033,0.001541146,0.0002233269,0.0009502576,0.1125384,0.0000707842,0.001317755,0.05323246],"study_design_scores_gemma":[0.0008693691,0.03841601,0.9425046,0.00001324518,0.000263489,0.003376452,0.0001697299,0.002103933,0.009771029,0.0000830299,0.002410314,0.00001875205],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9994443,0.0001195426,0.00005851596,0.00001523441,0.000003961917,0.00000998133,0.0001030115,0.000003517986,0.0002418038],"genre_scores_gemma":[0.9994426,0.00004816662,0.00004756208,0.0000188064,0.000007419512,0.000009315948,0.000229862,0.000001029453,0.0001952157],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001429731,"threshold_uncertainty_score":0.004782975,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404064412","doi":"10.1136/jitc-2024-sitc2024.0361","title":"361 Early differentiation and memory transcription programs drive long-term persistence of NY-ESO-1 specific TCR-T cells in adoptive cell therapy","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"T-cell receptor; Term (time); Persistence (discontinuity); Biology; Computer science; T cell; Immunology; Physics; Engineering; Immune system","authors":[{"name":"Marcus O Butler","is_ca":true},{"name":"Valentin Sotov","is_ca":true},{"name":"Dong-Hoon Han","is_ca":true},{"name":"Sam Saibil","is_ca":true},{"name":"Sarah Boross-Harmer","is_ca":true},{"name":"Linh T. Nguyen","is_ca":true},{"name":"Elizabeth Scheid","is_ca":true},{"name":"Dalam Ly","is_ca":true},{"name":"Sawako Elston","is_ca":true},{"name":"Meng Xu","is_ca":true},{"name":"Pamela S. Ohashi","is_ca":true},{"name":"Shinya Tanaka","is_ca":false},{"name":"Naoto Hirano","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.035798880816205,"gpt":0.2570067381479863,"spread":0.2212078573317813,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115473,0.0001775212,0.0001510707,0.00009429963,0.00009746563,0.0002219926,0.0001212749,0.0001816149,0.001342974],"category_scores_gemma":[0.00006869491,0.00007970546,0.0001231988,0.00007758071,0.0001630811,0.0001468027,0.0001173772,0.0005819119,0.0003812877],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000147865,"about_ca_system_score_gemma":0.0001513698,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002790986,"about_ca_topic_score_gemma":0.000487289,"domain_scores_codex":[0.999915,0.00001002906,0.000007527794,0.0000160748,0.000021719,0.00002971539],"domain_scores_gemma":[0.9999458,0.000007121494,0.00001813864,0.000008870697,0.000005863285,0.00001433843],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002231696,0.0001402475,0.0005115771,0.00001660474,0.000002799123,0.00004333582,0.00002322583,0.00007696031,0.9957223,0.0001034311,0.0001051363,0.003031185],"study_design_scores_gemma":[0.0001098663,0.004738711,0.01094752,0.000009856466,0.00003023494,0.000840319,0.00005964038,0.001392723,0.9774697,0.0001113936,0.004284105,0.000005972453],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971539,0.0004447937,0.001265734,0.00003407417,0.00001004794,0.00003741424,0.0001547418,0.00004990933,0.0008493361],"genre_scores_gemma":[0.9971477,0.0002220006,0.0008826944,0.00003972216,0.000005857421,0.00003970035,0.0002606446,0.000009699584,0.001392046],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001342974,"threshold_uncertainty_score":0.0044927,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404065332","doi":"10.1136/jitc-2024-sitc2024.0878","title":"878 The immunomodulatory impact of chemotherapy when combined with PD-1 blockade in resectable lung cancers","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal General Hospital; McGill University Health Centre","funders":"","keywords":"Blockade; Medicine; Chemotherapy; Lung; Oncology; Internal medicine; Cancer research; Receptor","authors":[{"name":"Sydney Connor","is_ca":false},{"name":"Jiajia Zhang","is_ca":false},{"name":"Khaled Sanber","is_ca":false},{"name":"Tianbei Zhang","is_ca":false},{"name":"Roni Rayes","is_ca":true},{"name":"Rulin Wang","is_ca":false},{"name":"Zhicheng Ji","is_ca":false},{"name":"Isha Gurumurthy","is_ca":false},{"name":"Dipika Singh","is_ca":false},{"name":"Julie S. Deutsch","is_ca":false},{"name":"Janis M. Taube","is_ca":false},{"name":"Srinivasan Yegnasubramanian","is_ca":false},{"name":"J. Spicer","is_ca":true},{"name":"Patrick F. Forde","is_ca":false},{"name":"Hongkai Ji","is_ca":false},{"name":"Drew M. Pardoll","is_ca":false},{"name":"Kellie N. Smith","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009662269831908502,"gpt":0.2611179576055441,"spread":0.2514556877736356,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004167534,0.000224976,0.0004206911,0.0003606942,0.0001270098,0.0003492764,0.0001675926,0.000141432,0.00436855],"category_scores_gemma":[0.0003783916,0.0001359396,0.0002436156,0.000293034,0.000179919,0.0001543522,0.0001707057,0.0004489894,0.0006509595],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000238109,"about_ca_system_score_gemma":0.0004015113,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007529477,"about_ca_topic_score_gemma":0.001702201,"domain_scores_codex":[0.9998013,0.00004480069,0.00001646025,0.00003687208,0.00006387886,0.00003673639],"domain_scores_gemma":[0.9998823,0.00002877895,0.00002705923,0.00001463204,0.0000220322,0.00002506846],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01385592,0.001372087,0.06086827,0.0006581714,0.0002462532,0.0003336775,0.0001295881,0.003162198,0.7243637,0.0003415755,0.0105677,0.1841009],"study_design_scores_gemma":[0.001346653,0.01051324,0.3981572,0.00008267008,0.0003745202,0.00114638,0.0002299856,0.01651499,0.5477887,0.0007582566,0.02304455,0.00004293696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907032,0.001591851,0.002055462,0.0002278472,0.00007712204,0.00007172473,0.002883395,0.0002021848,0.002187198],"genre_scores_gemma":[0.9873862,0.0007412121,0.004117704,0.0002418085,0.00004097254,0.0001756074,0.004831501,0.00009645923,0.00236858],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00436855,"threshold_uncertainty_score":0.01461422,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4415899279","doi":"10.1136/jitc-2025-sitc2025.1036","title":"1036 KAN-004, a metabolically complete live biotherapeutic product for the treatment of immune-related colitis","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Product (mathematics); Colitis; Ulcerative colitis; Inflammatory bowel disease; Inflammation","authors":[{"name":"James E. Berleman","is_ca":false},{"name":"Lee R. Swem","is_ca":false},{"name":"Kyle Jacoby","is_ca":false},{"name":"Peter J Diebold","is_ca":false},{"name":"K. Robertson","is_ca":false},{"name":"Aditya Bhalla","is_ca":false},{"name":"Jackson Mintz","is_ca":false},{"name":"Pallavi Murugkar","is_ca":false},{"name":"Hannah Bronson","is_ca":false},{"name":"Meriem Messaoudene","is_ca":false},{"name":"Anna Pérez","is_ca":false},{"name":"Wiam Belkaïd","is_ca":false},{"name":"Marguerite Prior","is_ca":false},{"name":"Philip Burnham","is_ca":false},{"name":"Hao Shi","is_ca":false},{"name":"Mark Weinberg","is_ca":false},{"name":"Bertrand Routy","is_ca":true},{"name":"Arielle Elkrief","is_ca":false},{"name":"Matthew P. Cheng","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0124908853177363,"gpt":0.2491996479293751,"spread":0.2367087626116388,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001331078,0.0003252981,0.0002589448,0.0002584668,0.0001526045,0.0002656474,0.0003807099,0.0005212792,0.010117],"category_scores_gemma":[0.0001030631,0.0001349275,0.0002802869,0.0001856984,0.0001950936,0.0001946744,0.0002205403,0.0009484523,0.002030932],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002261571,"about_ca_system_score_gemma":0.0004455803,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006040582,"about_ca_topic_score_gemma":0.0008023691,"domain_scores_codex":[0.9999214,0.00001525546,0.000003716543,0.00001187179,0.00002458732,0.00002311634],"domain_scores_gemma":[0.9999536,0.000007022395,0.000007791371,0.000005100927,0.000005595379,0.0000208801],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003819811,0.0006514824,0.0003503531,0.0002955824,0.0000394667,0.0003767414,0.00003592943,0.000551715,0.8771853,0.001244481,0.00362929,0.11182],"study_design_scores_gemma":[0.003916232,0.02364633,0.009402603,0.00008283947,0.0001626041,0.004229213,0.00007815829,0.002293057,0.8300635,0.0005279191,0.1255413,0.00005639988],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"other","genre_scores_codex":[0.8958486,0.02283301,0.01482736,0.001786564,0.0009241283,0.0005877182,0.004033048,0.001626665,0.05753299],"genre_scores_gemma":[0.9366775,0.007800138,0.007809013,0.0004873828,0.00006028117,0.0001711202,0.003693346,0.00008889535,0.04321237],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.010117,"threshold_uncertainty_score":0.03384471,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4415898701","doi":"10.1136/jitc-2025-sitc2025.0078","title":"78 Exploratory radiomics analysis in unresectable hepatocellular carcinoma treated with durvalumab alone or combined with tremelimumab or bevacizumab","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Durvalumab; Tremelimumab; Bevacizumab; Radiomics; Hepatocellular carcinoma; Nivolumab; Exploratory analysis","authors":[{"name":"Hanif Gabrani-Juma","is_ca":true},{"name":"Qin Li","is_ca":false},{"name":"Young S. Lee","is_ca":false},{"name":"Patricia McCoon","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01516017579874371,"gpt":0.250318711045627,"spread":0.2351585352468833,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002482003,0.0003879457,0.0006876421,0.0004559428,0.0002045871,0.0004082711,0.0002262768,0.0002984219,0.002744624],"category_scores_gemma":[0.0005270808,0.0001657999,0.0006382123,0.0003074551,0.0002763539,0.000224328,0.0002176322,0.0003021236,0.0004241922],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007322113,"about_ca_system_score_gemma":0.0003258363,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002043231,"about_ca_topic_score_gemma":0.001345971,"domain_scores_codex":[0.9998902,0.00001832527,0.000007208496,0.0000246232,0.00002184234,0.00003782551],"domain_scores_gemma":[0.9998019,0.00005456333,0.00003579142,0.00001888577,0.0000227377,0.00006608538],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1392875,0.002048724,0.4266616,0.000551762,0.000966699,0.05751487,0.0005056323,0.005270365,0.2138675,0.0007505791,0.004825728,0.1477491],"study_design_scores_gemma":[0.002674317,0.02411316,0.8664974,0.00006848943,0.002136597,0.03281213,0.0007210953,0.009087406,0.05000757,0.0008274465,0.01094288,0.0001114055],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962069,0.0006275329,0.0004438114,0.0001172262,0.00001601832,0.00005628154,0.0005100705,0.00003002679,0.001992163],"genre_scores_gemma":[0.9980528,0.0002006093,0.0003358166,0.00006588249,0.00002742863,0.00003964342,0.0006203669,0.00001575403,0.0006416679],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002744624,"threshold_uncertainty_score":0.009181678,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404052940","doi":"10.1136/jitc-2024-sitc2024.0103","title":"103 A deep-learning approach to guide acquisition region selection for Imaging Mass Cytometry","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"AI in cancer detection","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Mass cytometry; Computer science; Selection (genetic algorithm); Artificial intelligence; Deep learning; Machine learning; Chemistry","authors":[{"name":"F. R. N. Schneider","is_ca":false},{"name":"Smriti Kala","is_ca":false},{"name":"Clinton Hupple","is_ca":true},{"name":"James Mansfield","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01268774742898928,"gpt":0.2480845245117705,"spread":0.2353967770827812,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001519366,0.001311775,0.000863544,0.00118913,0.0006595018,0.001679511,0.002672133,0.001974076,0.009324846],"category_scores_gemma":[0.002641374,0.0007757173,0.00112554,0.0009724364,0.0005855374,0.0007759413,0.001670808,0.002161071,0.003804919],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001906272,"about_ca_system_score_gemma":0.002393096,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01241538,"about_ca_topic_score_gemma":0.01713706,"domain_scores_codex":[0.9994282,0.0001096306,0.00003425967,0.0001929174,0.000146634,0.00008825424],"domain_scores_gemma":[0.9992877,0.000224833,0.00005999325,0.00007516865,0.0002959822,0.00005631557],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.0002630712,0.0001673844,0.001463363,0.0001508953,0.0001130975,0.0001376063,0.0001164619,0.2143347,0.02323237,0.0110716,0.02146433,0.7274852],"study_design_scores_gemma":[0.00001278883,0.00003269966,0.0001813585,0.00001100248,0.000009027885,0.0000296333,0.0000154074,0.988675,0.00470551,0.002982852,0.003336001,0.000008843338],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.003312409,0.000103692,0.9913901,0.0001726683,0.00003118024,0.0001002866,0.0001540593,0.00355553,0.001180019],"genre_scores_gemma":[0.07037037,0.0001579691,0.9194909,0.0005130307,0.00004884366,0.0005157298,0.0009054326,0.0006091357,0.007388555],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01241538,"threshold_uncertainty_score":0.03119475,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388042528","doi":"10.1136/jitc-2023-sitc2023.0689","title":"689 Pharmacodynamic results with talquetamab and daratumumab in patients with relapsed/refractory multiple myeloma in TRIMM-2","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Daratumumab; Medicine; CD38; Pharmacodynamics; Internal medicine; Multiple myeloma; CD8; Oncology; Refractory (planetary science); Antibody; Monoclonal antibody; Pharmacology; Immunology; Gastroenterology; Bortezomib; Immune system; Pharmacokinetics; Stem cell; Biology; CD34","authors":[{"name":"Deeksha Vishwamitra","is_ca":false},{"name":"Sheri Skerget","is_ca":false},{"name":"M. Damiette Smit","is_ca":false},{"name":"Lien Vandenberk","is_ca":false},{"name":"Kalpana Bakshi","is_ca":false},{"name":"Sangmin Lee","is_ca":false},{"name":"Bhagirathbhai Dholaria","is_ca":false},{"name":"María‐Victoria Mateos","is_ca":false},{"name":"Ajai Chari","is_ca":false},{"name":"Paula Rodríguez‐Otero","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Niels WCJ van de Donk","is_ca":false},{"name":"Raluca Verona","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01426746225719454,"gpt":0.255296573393422,"spread":0.2410291111362274,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004677588,0.0002971485,0.0009248331,0.0002483996,0.0001976313,0.0005548963,0.0001905801,0.0003947016,0.001898006],"category_scores_gemma":[0.0006584134,0.0001493508,0.0008220193,0.0002410385,0.0001903919,0.0003240371,0.0001830083,0.0009819252,0.0003948915],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005226394,"about_ca_system_score_gemma":0.0003391639,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005999689,"about_ca_topic_score_gemma":0.001250018,"domain_scores_codex":[0.9998088,0.00006736035,0.00001389871,0.00003722891,0.00003227562,0.00004037558],"domain_scores_gemma":[0.9997305,0.00006300279,0.0000645959,0.00001426253,0.00001695547,0.0001107308],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4267815,0.01324751,0.1134889,0.0007015785,0.003480867,0.001563194,0.0004593687,0.00687431,0.1593176,0.0003056841,0.005835525,0.267944],"study_design_scores_gemma":[0.08382152,0.3303176,0.5012854,0.0001012259,0.004237644,0.004164089,0.0003096949,0.01542806,0.04025934,0.0007048008,0.01922332,0.0001472452],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963462,0.001822643,0.0001424196,0.0001953051,0.00002568429,0.00007478586,0.0003223374,0.00003386717,0.00103672],"genre_scores_gemma":[0.9984223,0.0003003159,0.0001962339,0.0002282997,0.00004403293,0.0000386712,0.000429953,0.000008713138,0.0003315971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001898006,"threshold_uncertainty_score":0.006349504,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404053084","doi":"10.1136/jitc-2024-sitc2024.0716","title":"716 A randomized phase II window of opportunity clinical trial of PD-1 +/- IL-4 inhibition in early-stage ER+ HER2- breast cancer","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Ottawa Hospital; McMaster University; Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Stage (stratigraphy); Oncology; Window of opportunity; Window (computing); Internal medicine; Medicine; Cancer; Computer science; Biology; Real-time computing","authors":[{"name":"Angel Arnaout","is_ca":false},{"name":"Megan Hopkins","is_ca":true},{"name":"Oleg Saldaña","is_ca":true},{"name":"Vanessa Lopez Ozuna","is_ca":true},{"name":"Vida Talebian","is_ca":true},{"name":"Drashti Jain","is_ca":true},{"name":"Gregory R. Pond","is_ca":true},{"name":"Teresa Petrocelli","is_ca":true},{"name":"Melanie Spears","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04585014480770896,"gpt":0.3498682161185697,"spread":0.3040180713108608,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001120101,0.001378752,0.001590343,0.0003191744,0.0004092753,0.00102304,0.0005599406,0.00133389,0.009839482],"category_scores_gemma":[0.0007167247,0.0005304726,0.001059321,0.0002269183,0.0009411478,0.0007985553,0.0003861278,0.002406598,0.00132899],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005893703,"about_ca_system_score_gemma":0.001333046,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000677912,"about_ca_topic_score_gemma":0.001803071,"domain_scores_codex":[0.9996613,0.0001498787,0.00001281487,0.00005670737,0.00002237651,0.000096826],"domain_scores_gemma":[0.9995133,0.00009073329,0.00007537758,0.00004251785,0.00002687537,0.0002511283],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9666047,0.01362004,0.0004554872,0.0001761623,0.0002181676,0.00003916602,0.00003735131,0.0003278752,0.005587717,0.0001753213,0.001543468,0.01121454],"study_design_scores_gemma":[0.8509102,0.1453855,0.001093799,0.00001205022,0.0001315888,0.00003404807,0.00002006994,0.0003626748,0.000629476,0.0002709011,0.001136098,0.00001354147],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.985667,0.001379312,0.0004852428,0.0009127798,0.0006025172,0.006137727,0.00150583,0.0001047549,0.003204881],"genre_scores_gemma":[0.9765728,0.001227937,0.001642426,0.001871909,0.0005499713,0.008587977,0.001857967,0.00003911802,0.00764986],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009839482,"threshold_uncertainty_score":0.03291631,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308398717","doi":"10.1136/jitc-2022-sitc2022.0261","title":"261 Evidence for durable anti-tumor responses by TAC-T cells in preclinical models of solid tumors","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Cancer research; Flow cytometry; T cell; Antigen; Bone marrow; Immune system; Cytotoxic T cell; Biology; Molecular biology; Immunology; In vitro","authors":[{"name":"Heather MacGregor","is_ca":false},{"name":"Duane Moogk","is_ca":true},{"name":"Stacey X. Xu","is_ca":false},{"name":"Joanne A. Hammill","is_ca":true},{"name":"Philbert Ip","is_ca":false},{"name":"Ling Wang","is_ca":false},{"name":"Swati Shetty","is_ca":false},{"name":"Kyle MacDonald","is_ca":false},{"name":"Laura Shaver","is_ca":false},{"name":"Sailaja Pirati","is_ca":false},{"name":"Prabha Lal","is_ca":false},{"name":"Christopher W. Helsen","is_ca":false},{"name":"Jonathan L. Bramson","is_ca":true},{"name":"Sadhak Sengupta","is_ca":false},{"name":"Andreas G. Bader","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09622014376030799,"gpt":0.3660636532016021,"spread":0.2698435094412941,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003030869,0.000450033,0.0003576424,0.0003280693,0.0001778709,0.0003647764,0.0002392074,0.0004112255,0.003385001],"category_scores_gemma":[0.0002088269,0.0001454904,0.0003176405,0.0001834271,0.0002892855,0.0002305568,0.0001141861,0.001549288,0.001198777],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002145015,"about_ca_system_score_gemma":0.0002863661,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005199041,"about_ca_topic_score_gemma":0.0005768751,"domain_scores_codex":[0.9997477,0.00004274475,0.0000225115,0.00005230542,0.00006944359,0.0000652473],"domain_scores_gemma":[0.9997484,0.00003782173,0.00006278577,0.00004108604,0.00004409617,0.0000657414],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001428109,0.0009315668,0.0004340037,0.0001253781,0.00001955954,0.0001206391,0.00003915758,0.0002371584,0.9896912,0.0001818164,0.0008388424,0.005952386],"study_design_scores_gemma":[0.0002568985,0.01679034,0.006478998,0.00003409955,0.00007569748,0.001027522,0.00008167585,0.001664706,0.9645748,0.0001920649,0.008809433,0.00001378214],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9805846,0.003652189,0.004717647,0.0004323013,0.0002268268,0.0002152117,0.002122929,0.000376988,0.007671359],"genre_scores_gemma":[0.9840747,0.001702028,0.002679863,0.0003152142,0.00008267493,0.0002269401,0.00352703,0.00008007477,0.007311456],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003385001,"threshold_uncertainty_score":0.01132399,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388042304","doi":"10.1136/jitc-2023-sitc2023.1257","title":"1257 Augmenting post-market surveillance of serious drug-induced adverse events with artificial intelligence (AI)-aggregated case reports: proof-of-concept for PD-1/PD-L1 inhibitors for NSCLC","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Adverse Event Reporting System; Adverse effect; Medicine; Internal medicine","authors":[{"name":"Suad Kabbaha","is_ca":false},{"name":"Sarah Carder Dempsey","is_ca":false},{"name":"Aranka Anema","is_ca":false},{"name":"Sonal Singh","is_ca":false},{"name":"Kristian Thorlund","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06243865175087545,"gpt":0.3720942539833658,"spread":0.3096556022324903,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03464384,0.0005701524,0.0006841929,0.009393592,0.000524937,0.003513075,0.001253691,0.00105807,0.007077997],"category_scores_gemma":[0.1583124,0.0003463138,0.001931777,0.004709114,0.0006560004,0.002164989,0.002411664,0.0007868133,0.001824628],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001071982,"about_ca_system_score_gemma":0.004132996,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002176671,"about_ca_topic_score_gemma":0.0037914,"domain_scores_codex":[0.9771227,0.009267759,0.007356649,0.001548022,0.004295964,0.0004089466],"domain_scores_gemma":[0.81151,0.1060763,0.04401059,0.01472737,0.02180444,0.001871326],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.002310788,0.0006305385,0.3432617,0.02612423,0.001900167,0.00304379,0.002154893,0.003754363,0.004137862,0.005613255,0.08343416,0.5236343],"study_design_scores_gemma":[0.001623116,0.002296417,0.3643754,0.0266342,0.004669872,0.008130312,0.00341994,0.02027447,0.01715569,0.01472624,0.5363129,0.0003814649],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4833061,0.06624377,0.1089138,0.01804941,0.002264456,0.02169461,0.2505321,0.003625257,0.04537048],"genre_scores_gemma":[0.6283435,0.01707979,0.1967836,0.004464558,0.001705043,0.008426039,0.139283,0.0003274963,0.003586888],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03464384,"threshold_uncertainty_score":0.1832163,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308375764","doi":"10.1136/jitc-2022-sitc2022.0059","title":"59 DetermaIO (IO score) is associated with efficacy of ICI monotherapy in advanced NSCLC patients: a retrospective BC Cancer study","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Internal medicine; Medicine; Cohort; Oncology; Retrospective cohort study; Chemotherapy; Cancer; Combination therapy; PD-L1; Immunotherapy","authors":[{"name":"David J. Saltman","is_ca":false},{"name":"Nicole S. Croteau","is_ca":true},{"name":"Heather Lockyer","is_ca":false},{"name":"Robert S. Seitz","is_ca":false},{"name":"Frank McMahon","is_ca":false},{"name":"Jeremy Spille","is_ca":false},{"name":"Andrea M. Dickey","is_ca":false},{"name":"Jordan Jennings","is_ca":false},{"name":"Matthew G. Varga","is_ca":false},{"name":"Kimberly McGregor","is_ca":false},{"name":"Tyler J. Nielsen","is_ca":false},{"name":"David R. Hout","is_ca":false},{"name":"Brock L. Schweitzer","is_ca":false},{"name":"Douglas A. Ross","is_ca":false},{"name":"David R. Gandara","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01331247988039141,"gpt":0.2563421330334675,"spread":0.2430296531530761,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004771474,0.0001637257,0.0002811567,0.0005373793,0.0003332718,0.0005863562,0.0001950916,0.0003065352,0.001196478],"category_scores_gemma":[0.0007915116,0.00018627,0.0005450332,0.0007619649,0.0001973308,0.000210128,0.0002891992,0.0003303835,0.0002896398],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003116826,"about_ca_system_score_gemma":0.0002373323,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003658087,"about_ca_topic_score_gemma":0.005478309,"domain_scores_codex":[0.9996351,0.00004978895,0.00004336536,0.0001443237,0.00006995007,0.00005745788],"domain_scores_gemma":[0.999335,0.00009853796,0.0002527202,0.00008882539,0.0001106135,0.0001142258],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001936846,0.00001065112,0.9981145,0.00001069338,0.00006889323,0.0000335706,0.00001834218,0.00002708114,0.0004607696,0.000009159225,0.0001195507,0.0009332065],"study_design_scores_gemma":[0.000008004905,0.00007112091,0.998809,0.000004248041,0.00006362452,0.000196887,0.00005244513,0.0001552322,0.0001664841,0.00001657029,0.0004530756,0.000003390945],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974311,0.0005090265,0.0001446401,0.00002151688,0.000008672728,0.00001783877,0.001161275,0.000004169392,0.0007017244],"genre_scores_gemma":[0.9986539,0.00009175871,0.00007606912,0.00002970184,0.000007865078,0.00001572205,0.0009759261,0.000003101585,0.0001459493],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003658087,"threshold_uncertainty_score":0.007273614,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3212553475","doi":"10.1136/jitc-2021-sitc2021.466","title":"466 Use of a 27-gene immuno-oncology (IO) assay to associate response to single-agent immune checkpoint inhibitor (ICI) therapy in advanced-stage NSCLC patients from a large Canadian cohort","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of British Columbia","funders":"","keywords":"Oncology; Medicine; Internal medicine; Lung cancer; Cancer; Targeted therapy; Biomarker; Breast cancer; Immunotherapy; Immunohistochemistry; Biology","authors":[{"name":"David L. Saltman","is_ca":false},{"name":"Nicole S. Croteau","is_ca":true},{"name":"Heather Lockyer","is_ca":false},{"name":"Rob Seitz","is_ca":false},{"name":"Frank B. McMahon","is_ca":false},{"name":"Jeremy Spille","is_ca":false},{"name":"Andrea M. Dickey","is_ca":false},{"name":"Matthew G. Varga","is_ca":false},{"name":"Kim McGregor","is_ca":false},{"name":"Tyler J. Nielsen","is_ca":false},{"name":"David R. Hout","is_ca":false},{"name":"Brock L. Schweitzer","is_ca":false},{"name":"Douglas S. Ross","is_ca":false},{"name":"David R. Gandara","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02346754772782018,"gpt":0.2608376512464363,"spread":0.2373701035186161,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006324295,0.0003343758,0.0003656746,0.001027243,0.001119581,0.0007722295,0.0006222884,0.0003935525,0.001396648],"category_scores_gemma":[0.0009895769,0.0002268363,0.0005634868,0.001307423,0.000455518,0.000135849,0.0003272135,0.000546564,0.0004429507],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006810131,"about_ca_system_score_gemma":0.005379213,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7731179,"about_ca_topic_score_gemma":0.8385596,"domain_scores_codex":[0.9993653,0.00004259182,0.00002810204,0.000188594,0.0002276844,0.000147742],"domain_scores_gemma":[0.9988968,0.00006923538,0.0001381524,0.00006836379,0.0006374251,0.000190027],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003871776,0.00007579969,0.9843322,0.00003568695,0.00006375321,0.0001845114,0.0003581049,0.0001746577,0.004577643,0.00006476633,0.001913437,0.007832205],"study_design_scores_gemma":[0.00002463894,0.0002000188,0.9932281,0.000009045663,0.00005234951,0.0003532593,0.000372714,0.0006983868,0.00109896,0.00001852859,0.003925237,0.00001869105],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900541,0.0003761161,0.0004541224,0.0001620595,0.00002351396,0.0001459226,0.006386273,0.00003310915,0.002364673],"genre_scores_gemma":[0.9921777,0.0002462731,0.0009556955,0.0002680842,0.00001591903,0.00009517821,0.004407985,0.0000177165,0.001815441],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2268821,"threshold_uncertainty_score":0.4564365,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388072441","doi":"10.1136/jitc-2023-sitc2023.0866","title":"866 The effect of butyrophilin 1A1 blockade in combination with radiation treatment in colon and Lewis lung carcinoma","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Radioresistance; Cancer research; Lung cancer; Lewis lung carcinoma; Apoptosis; Medicine; CD44; Radiation therapy; Flow cytometry; Pathology; Cell; Biology; Cancer; Internal medicine; Immunology; Metastasis","authors":[{"name":"Steven H. Lin","is_ca":false},{"name":"Stephen Yoo","is_ca":false},{"name":"Nan Li","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008263332487901847,"gpt":0.2419024171837194,"spread":0.2336390846958175,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002436288,0.0004469506,0.0006544755,0.0003355315,0.0002256101,0.000253388,0.0002426945,0.0003758044,0.002757563],"category_scores_gemma":[0.0001362741,0.0001831412,0.0007240422,0.0002062682,0.0002403418,0.0002091039,0.0001834517,0.0009191906,0.000483377],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002151581,"about_ca_system_score_gemma":0.0005167589,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001836514,"about_ca_topic_score_gemma":0.003288127,"domain_scores_codex":[0.9998673,0.00003649256,0.00001313295,0.00001663926,0.00002110318,0.00004536802],"domain_scores_gemma":[0.9998751,0.00001824081,0.00001763594,0.00001298824,0.00001388829,0.00006211906],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.01142448,0.002819971,0.0009217131,0.000603989,0.0001083724,0.0004130867,0.00008663942,0.0004850405,0.9653058,0.0001299223,0.001239642,0.01646128],"study_design_scores_gemma":[0.002407286,0.08323625,0.02087836,0.00007421365,0.0003245438,0.001005224,0.0003189014,0.002989655,0.8765548,0.0001516575,0.01200111,0.00005790468],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922829,0.004000584,0.0003123111,0.0003032117,0.0002277518,0.00009268482,0.0003661478,0.00008917203,0.002325172],"genre_scores_gemma":[0.9939062,0.00206456,0.0007015834,0.00019413,0.00004084502,0.0001073201,0.000510006,0.00001317836,0.00246224],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002757563,"threshold_uncertainty_score":0.009224892,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388042588","doi":"10.1136/jitc-2023-sitc2023.0347","title":"347 Functional characterization of GUCY2C-TAC T cells for the treatment of colorectal cancer using preclinical models","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"In vivo; Cancer research; Receptor; In vitro; Antigen; Cancer; Cancer cell; Colorectal cancer; Cytotoxic T cell; Chemistry; Cell biology; Biology; Medicine; Immunology; Internal medicine; Biochemistry","authors":[{"name":"Tania Benatar","is_ca":false},{"name":"Thanyashanthi Nitya-Nootan","is_ca":false},{"name":"Suzanna L. Prosser","is_ca":false},{"name":"Philbert Ip","is_ca":false},{"name":"Prabha Lal","is_ca":false},{"name":"Alima Naim Khan","is_ca":false},{"name":"Stacey X. Xu","is_ca":false},{"name":"Sailaja Pirati","is_ca":false},{"name":"Christopher W. Helsen","is_ca":false},{"name":"Andreas G. Bader","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1143137484958757,"gpt":0.3484156745680693,"spread":0.2341019260721936,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002061221,0.0003740311,0.000249584,0.0001942687,0.0001186594,0.0002297626,0.0001848804,0.0003661228,0.001439681],"category_scores_gemma":[0.0001181487,0.00008714227,0.0002564975,0.0001520323,0.0001221233,0.0001119759,0.00006560751,0.0005565326,0.000613859],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002774098,"about_ca_system_score_gemma":0.0001941772,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001238134,"about_ca_topic_score_gemma":0.0007165109,"domain_scores_codex":[0.9998682,0.00002537269,0.00001062931,0.00001952898,0.0000397425,0.00003659237],"domain_scores_gemma":[0.9999279,0.00001277059,0.00001298206,0.000007550467,0.00001895676,0.00001989215],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001819742,0.0001372525,0.00008109306,0.00003301691,0.000004835875,0.00004017718,0.00001342971,0.000267396,0.9976141,0.00009100181,0.000131192,0.001404423],"study_design_scores_gemma":[0.00006058572,0.002641032,0.001250571,0.000005231876,0.00002157203,0.0001921327,0.00001914407,0.002283219,0.9906741,0.00003229214,0.002814224,0.000005889125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9867661,0.00131702,0.00688579,0.0001965336,0.00005918763,0.00028778,0.00150026,0.0001212468,0.002866127],"genre_scores_gemma":[0.9866194,0.0008341388,0.00604908,0.0001440019,0.00002038405,0.0002919222,0.002588159,0.00003425563,0.003418723],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001439681,"threshold_uncertainty_score":0.004816234,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404052762","doi":"10.1136/jitc-2024-sitc2024.1011","title":"1011 Metabolic reprogramming alters natural killer cell responses in chronic graft-versus-host disease","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Reprogramming; Disease; Host (biology); Graft-versus-host disease; Cell; Biology; Immunology; Medicine; Ecology; Genetics; Internal medicine","authors":[{"name":"Ao Mei","is_ca":false},{"name":"Madeline Lauener","is_ca":true},{"name":"Kirk R. Schultz","is_ca":true},{"name":"Subramaniam Malarkannan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01370699216750275,"gpt":0.2467111888803851,"spread":0.2330041967128824,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009898146,0.0001569491,0.0001525149,0.0001761338,0.0001089261,0.0002469196,0.000100914,0.0002430882,0.002448278],"category_scores_gemma":[0.00008669494,0.0000687335,0.0001891079,0.0001353475,0.0001909404,0.000150535,0.0001243014,0.0002986991,0.0003981588],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001569557,"about_ca_system_score_gemma":0.0001026806,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002033816,"about_ca_topic_score_gemma":0.0002082932,"domain_scores_codex":[0.9998972,0.00001847159,0.00001173966,0.00002645731,0.00001532436,0.00003070165],"domain_scores_gemma":[0.9999607,0.000006319583,0.00001125033,0.000005005303,0.000003625458,0.00001321421],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001007244,0.000120657,0.004562472,0.00004377349,0.00001453606,0.0001592767,0.00003161015,0.00007745325,0.9895546,0.0001114908,0.0001054628,0.004211396],"study_design_scores_gemma":[0.0001821139,0.004520134,0.2597685,0.00002697124,0.0001043491,0.002408387,0.0003740686,0.001580676,0.7221356,0.0006487955,0.00822643,0.00002400652],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980141,0.0005059314,0.00034846,0.00004295934,0.00002278383,0.0000126382,0.0003277608,0.00001555497,0.0007096608],"genre_scores_gemma":[0.9981412,0.000263914,0.0002457583,0.0000968553,0.000008137989,0.00003239025,0.0005467841,0.000009177621,0.0006558269],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002448278,"threshold_uncertainty_score":0.008190334,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388048268","doi":"10.1136/jitc-2023-sitc2023.0838","title":"838 Oncolytic virus induced tumour-infiltrating lymphocytes (TILs) for the treatment of colorectal cancer","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Ottawa Hospital; Agricultural Research Institute of Ontario; University of Ottawa","funders":"","keywords":"Oncolytic virus; Tumor-infiltrating lymphocytes; Medicine; Adoptive cell transfer; Colorectal cancer; Tumor microenvironment; Cancer research; Immunotherapy; Cancer; Immune system; Immunology; T cell; Internal medicine","authors":[{"name":"Sydney Vallati","is_ca":true},{"name":"Mathieu J. F. Crupi","is_ca":true},{"name":"Zaid Taha","is_ca":true},{"name":"Julia Petryk","is_ca":true},{"name":"Bradley Austin","is_ca":true},{"name":"Victoria H. Gilchrist","is_ca":true},{"name":"Nouf Alluqmani","is_ca":true},{"name":"Stephen Boulton","is_ca":true},{"name":"John C. Bell","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03767717695858579,"gpt":0.3190140528143015,"spread":0.2813368758557157,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001965509,0.00030214,0.0001800881,0.0003128824,0.0001143268,0.0002201655,0.0001586111,0.000267541,0.001851599],"category_scores_gemma":[0.00008835919,0.00008900808,0.0002215034,0.0001642858,0.0001561913,0.0001454205,0.0001521824,0.0006420222,0.0005082786],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002376226,"about_ca_system_score_gemma":0.0003372888,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005202884,"about_ca_topic_score_gemma":0.0009508287,"domain_scores_codex":[0.999897,0.00002008762,0.000008470114,0.00001545548,0.00003634676,0.00002267771],"domain_scores_gemma":[0.999948,0.000009310939,0.0000132053,0.000005374675,0.000009952741,0.00001421401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000304585,0.0001206785,0.0002220832,0.0001125958,0.00000711113,0.00003546787,0.0000142445,0.0001281664,0.9874981,0.0001346912,0.0003756968,0.01104661],"study_design_scores_gemma":[0.0001074989,0.002327857,0.003762545,0.00003033163,0.00002866195,0.0004587223,0.00002153421,0.001193564,0.9748779,0.0001127294,0.01706933,0.000009306709],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9424461,0.01546158,0.02916078,0.0008344991,0.0003142355,0.0009255974,0.002298588,0.0007659449,0.007792714],"genre_scores_gemma":[0.9598355,0.006900481,0.02321828,0.0004038353,0.00006313746,0.0005702877,0.001656273,0.00009316609,0.007259105],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001851599,"threshold_uncertainty_score":0.006194174,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3105826467","doi":"10.1136/jitc-2020-sitc2020.0075","title":"75 Generalizability of potential biomarkers of response to CTLA-4 and PD-1 blockade therapy in cancer","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Generalizability theory; Blockade; CTLA-4; Cancer; Cancer therapy; Medicine; Oncology; Internal medicine; Immunology; Immune system; Mathematics; T cell; Receptor; Statistics","authors":[{"name":"Dante S. Bortone","is_ca":false},{"name":"Steven Vensko","is_ca":false},{"name":"Sarah Entwistle","is_ca":false},{"name":"Alexandria P. Cogdill","is_ca":false},{"name":"Anne Monette","is_ca":true},{"name":"Yana G. Najjar","is_ca":false},{"name":"Randy F. Sweis","is_ca":false},{"name":"Nicholas Tschernia","is_ca":false},{"name":"Erik Wennerberg","is_ca":false},{"name":"Praveen K. Bommareddy","is_ca":false},{"name":"Cara Haymaker","is_ca":false},{"name":"Uqba Khan","is_ca":false},{"name":"Heather M. McGee","is_ca":false},{"name":"Wungki Park","is_ca":false},{"name":"Houssein Abdul Sater","is_ca":false},{"name":"Christine N. Spencer","is_ca":false},{"name":"Maria Libera Ascierto","is_ca":false},{"name":"Valentin Barsan","is_ca":false},{"name":"Vinita Popat","is_ca":false},{"name":"Sara Valpione","is_ca":false},{"name":"Danny Wells","is_ca":false},{"name":"Vésteinn Thórsson","is_ca":false},{"name":"Roberta Zappasodi","is_ca":false},{"name":"Nils-Petter Rudqvist","is_ca":false},{"name":"Benjamin G. Vincent","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02573454979681641,"gpt":0.2777691241262219,"spread":0.2520345743294055,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02935154,0.0004311512,0.0007298687,0.002370466,0.0004052526,0.002057728,0.0006368294,0.0006724089,0.003031672],"category_scores_gemma":[0.05141931,0.0002891159,0.002254179,0.002612528,0.001286056,0.0008056728,0.00165094,0.000708657,0.0005630087],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006899001,"about_ca_system_score_gemma":0.0007352091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002664439,"about_ca_topic_score_gemma":0.002181778,"domain_scores_codex":[0.9857486,0.006568808,0.001585796,0.003940146,0.001693218,0.0004634317],"domain_scores_gemma":[0.9496941,0.03656404,0.003921334,0.007494854,0.00196833,0.000357366],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002471807,0.0001080601,0.8959882,0.0005385719,0.004830839,0.0001922665,0.0004924669,0.01199534,0.01107481,0.0008065961,0.002628065,0.06887301],"study_design_scores_gemma":[0.0001425392,0.0009074978,0.9615269,0.0001063976,0.001722824,0.0004237027,0.0004063052,0.01665614,0.005299037,0.004729852,0.008020425,0.00005838922],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9330944,0.003799109,0.04050956,0.001191499,0.000146138,0.0003540689,0.01523941,0.0007209001,0.004944867],"genre_scores_gemma":[0.9884659,0.0001836304,0.004111835,0.000434553,0.00006407995,0.0001849499,0.00615595,0.0001185601,0.0002804912],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02935154,"threshold_uncertainty_score":0.1552277,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308400766","doi":"10.1136/jitc-2022-sitc2022.0913","title":"913 Translational analysis of advanced metastatic bladder cancer patients treated with IO combination maveropepimut-S, cyclophosphamide, and pembrolizumab","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"ELISPOT; Immune system; Medicine; Immunotherapy; Immunology; Antigen; T cell; Cancer research; Pembrolizumab","authors":[{"name":"Heather Torrey","is_ca":false},{"name":"Walead Ebrahimizadeh","is_ca":false},{"name":"Valarmathy Kaliaperumal","is_ca":false},{"name":"Aurelio Lobo","is_ca":false},{"name":"Barry E. Kennedy","is_ca":false},{"name":"Tran B. Ngo","is_ca":false},{"name":"Lisa D. MacDonald","is_ca":false},{"name":"Stephan Fiset","is_ca":false},{"name":"Jeremy R. Graff","is_ca":false},{"name":"Heather A. Hirsch","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009540570406654516,"gpt":0.2399653680186305,"spread":0.230424797611976,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002440738,0.0001911885,0.0004528064,0.0001570343,0.0002372493,0.0002814676,0.0001078033,0.000243231,0.001488489],"category_scores_gemma":[0.0001699186,0.0001160689,0.0003521568,0.0002397353,0.000206695,0.0001441723,0.0001241144,0.0003300574,0.0002066712],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003427823,"about_ca_system_score_gemma":0.0004054959,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009812551,"about_ca_topic_score_gemma":0.001341406,"domain_scores_codex":[0.9999026,0.00002787642,0.0000070856,0.0000234891,0.00001783545,0.00002111939],"domain_scores_gemma":[0.9999061,0.00001051425,0.00002326229,0.000007699659,0.0000162086,0.00003629548],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.09640513,0.005791652,0.3248028,0.0004282309,0.0004577586,0.001351269,0.0004169134,0.001338266,0.491927,0.0001800269,0.001968706,0.0749322],"study_design_scores_gemma":[0.002047506,0.05755217,0.9044097,0.00002450934,0.0005087156,0.00140246,0.0002659551,0.002415998,0.02724108,0.00009822011,0.004008565,0.00002509328],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"other","genre_scores_codex":[0.9989981,0.0002435518,0.00008397393,0.00003701146,0.000007912675,0.00003977148,0.000182853,0.000006056533,0.0004006953],"genre_scores_gemma":[0.9986795,0.0001170582,0.0001648769,0.00008117285,0.00001460098,0.00006027388,0.0005142751,0.000002710752,0.0003655156],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.001488489,"threshold_uncertainty_score":0.004979432,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}